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Overview: This thesis explored the concept of stigma as experienced by people with 
functional neurological disorder (FND) and assessed a mindfulness-based intervention for 
people experiencing functional seizures (FS). 
 
Systematic Literature Review: The systematic literature review used a qualitative meta-
synthesis approach to explore the experience of stigma amongst people experiencing FND. 
The review identified four themes: delegitimization; excluded, isolated and abandoned – the 
social cost of stigma; the cost of attempts to manage stigma and; threats to identity and the 
meaning of mental health. Stigma appears to be a central experience for those with an FND 
diagnosis. 
 
Empirical Paper: The empirical paper comprised of a single case experimental design 
(SCED) which assessed the effect of a mindfulness training intervention delivered through a 
smartphone app for people experiencing FS. Four participants completed the study and a fifth 
completed it partially. Results found that two participants showed reliable and clinically 
significant changes on the outcome measure of quality of life and distress as well as process 
measures of experiential avoidance and mindfulness. However, clinically significant 
outcomes were not observed for the remainder. The implications of these results are 
discussed. 
 
Critical Appraisal: This paper shared reflections on the process of this research and provided 
additional background to some of the key decisions taken over the course of the study while 
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This meta-ethnography explored the experience of stigma amongst people with a diagnosis of 
functional neurological disorder (FND). Whilst stigma is regularly reported by this group in 
qualitative research, there are a limited number of studies that focus explicitly on this 
experience. The aim of this review was to develop a further understanding of how people 
with FND experience stigma. Five databases were searched (PsycINFO, Web of Science, 
CINAHL, MEDLINE and EMBASE) and following a screening process and a critical 
appraisal using the CASP tool, 13 papers were included in the final synthesis. Four major 
themes emerged; delegitimization; excluded, isolated and abandoned – the social cost of 
stigma; the cost of attempts to manage stigma and; threats to identity and the meaning of 
mental health. The results identified negative, stigmatizing attitudes towards people 
experiencing FND symptoms in a variety of contexts including healthcare and other social 
institutions. Additionally, the effects of stigma led to further exclusion for participants and 
appeared to trigger coping styles that led to additional difficulty. This review identifies 
stigma as a key part of the illness experience of FND and highlights the need for stigma 
towards this group to be addressed. 
 
Keywords; Functional neurological disorder, stigma, meta-ethnography, functional movement 








1.1 Functional neurological disorder 
Functional neurological disorder (FND) describes the experience of neurological symptoms 
which cannot be completely explained by existing understandings of neurological pathology. 
The symptoms of FND can resemble neurological conditions such as epilepsy, stroke or 
Parkinson’s. However, FND doesn’t present with similarly identifiable biomarkers as these 
organic illnesses. FND has an estimated incidence rate of 4-12 per 100,000 per annum 
worldwide [1] and a large-scale study in Scotland found that FND was the second most 
frequent complaint in first-time presentations to outpatient neurology after headache [2].  
 
The symptoms of FND are wide ranging and can include seizures, tremor and spasm among 
others [3]. Research on the prognosis for people with FND has shown that for many people 
these difficulties are enduring, with follow up studies highlighting that a large proportion of 
people diagnosed with this condition continue to experience difficulty, or indeed an increase 
in the severity of the condition over time [4]. 
 
In addition to the primary symptoms of FND, people with this diagnosis experience a range 
of wider difficulties including in their family, work and social lives as a result of their 
condition [5]. Furthermore, many people with the condition experience mental health 
difficulties such as anxiety and depression [1]; with these being more common than for 
individuals with a corresponding organic diagnosis [6]. For many with the condition, the 
combination of FND and associated difficulties cause a degree of disability and impact on 
participation in everyday activities. For example, a case-control study reported a significant 
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drop in employment levels  in a sample of 322 people with an FND diagnosis, falling from 
87.5% before experiencing symptoms to 24.5% post diagnosis [7]. 
 
1.2 History & current understandings of FND 
FND has a long history, throughout which understandings of the condition have been in a 
state of flux. Early descriptions date back to ancient Greece [8]. At this time, symptoms 
associated with this condition were labelled as “hysteria” which at the time was perceived to 
be caused by a range of abnormalities of the womb such as “wandering of the womb” or 
“suffocation of the womb” [8]. The middle ages led to associations between FND symptoms 
and witchcraft resulting in severe consequences for individuals with the condition [8]. 
Subsequently, understandings of FND symptoms moved away from earlier supernatural and 
womb-based explanations to attribute a greater role to the brain and the mind in their origin. 
Charcot proposed a variety of understandings of FND including the role of “dynamic lesions” 
on the brain [9], a hereditary component [10] and later noted psychological aspects of the 
condition such as a correlation with past trauma [9]. Freud was greatly influenced by Charcot 
and went on to develop psychoanalysis positing that FND symptoms were a physical 
representation of unconscious struggle, coining the term “conversion” to describe this [9]. 
 
To this date, no universally accepted explanation of FND is available. More recent 
explanations of FND have built on the understandings that the brain and the mind play a key 
role in their development and maintenance. Neurobiological investigations have found that 
while no specific brain lesion or abnormality can explain FND, differences in activation and 
connectivity in specific brain areas have been observed [11]. For example, hypoactivation has 
been observed in the motor cortex of those with functional tremor [12] and strong functional 
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connectivity has been observed between areas associated with emotion, movement and 
executive function in those experiencing functional seizures [13]. 
  
Psychological explanations build on those proposed by Charcot and Freud. Modern 
psychodynamic explanations posit the role of FND symptoms in the unconscious 
management of feelings, interactions or memories that are unbearable in some way [14]. 
However, this explanation is contested due to the lack of a clear traumatic event in many 
cases of FND [15]. Further psychological explanations focus on links between the attentional 
system, illness beliefs and FND symptoms [16]. Beyond this, cognitive explanations 
highlight schemas or frames of understanding that underpin FND and result in symptoms 
when activated [17]. 
 
Biopsychosocial explanations of illness seek to integrate these various understandings into a 
meaningful whole, integrating the impact of each factor upon the development and 
maintenance of the condition. Models encompassing cognitive, attentional and affective 
processes alongside social and biological vulnerabilities [18] facilitate the integration of 
different understandings of FND and allow for the heterogeneity that exists amongst those 
who develop these symptoms. 
 
1.3 Stigma 
Due to the lack of specific biomarkers of disease, stigma is a common experience for those 
with FND [19]. The term stigma originated in ancient Greece where it was used to describe a 
physical trait or characteristic that denoted an individual as somehow tainted, immoral or 
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someone who should be avoided [20]. Current understandings of stigma have been heavily 
influenced by Goffmann [21] who defined stigma as a social construct as a devaluation of 
social identity which prevents individuals from attaining full social acceptance. Link & 
Phelan [22] further emphasised the impact that stigma has in highlighting difference between 
people or groups, developing a “them” and “us” narrative which ultimately leads to 
discrimination, power imbalance and loss of status for those affected.  
 
There is growing interest in stigma in the field of health research. Stigma has an impact on 
health outcomes for those affected. For example, access to life chances such as employment 
and effective treatment are limited to those affected by stigma and the stress caused by the 
experience of stigma can exacerbate existing health difficulties [22]. 
 
Highlighting the extent of stigma for people with this condition, FNDHope, an international 
patient-led charity providing support and advocacy for people with FND, conducted a survey 
of people with FND in 2020 [23]. This survey found that 81% of participants reported being 
treated poorly due to stigma related to their diagnosis. A large proportion (61%) of the 
sample also reported that they experienced trauma as a result of their illness journey. Further 
questions showed that a large number of respondents (61.8%) believe that having an FND 
diagnosis had affected the healthcare provided in the past and more (64%) were concerned 
about how it would affect future healthcare. The results of this survey are reflected in 
research on stigma in one particular FND, functional seizures (FS), where an exploratory 
study found that 82.7% of a UK based sample of 47 individuals with a diagnosis of FS 
experienced perceived stigma [6]. The same study compared those with the FND diagnosis of 
FS to the corresponding organic condition of epilepsy finding that those with the FND 
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diagnosis were 42% more likely to experience perceived stigma. Furthermore, quantitative 
research has highlighted the role that stigma plays in exacerbating difficulties with quality of 
life in the domains of seizure worry, emotional wellbeing and social functioning for those 
experiencing FND symptoms [24]. 
 
Considering the experience of healthcare professionals, research has highlighted stigmatizing 
beliefs towards people experiencing FND [25]. Clinicians have expressed stigmatizing beliefs 
including the idea that those with FND symptoms are “faking” their illness in order to benefit 
from secondary gain [26]. A synthesis of studies on the views of healthcare providers 
working with FND highlights a vicious circle of stigma [25]. In this explanation, the review 
identified struggles that healthcare professionals experience in managing the complexity of 
the presentation of people with FND leading to them “passing the buck” [25 p. 7] on to 
another discipline without providing adequate support. 
 
As well as the quantitative research into stigma in FND, stigma has been reported in a variety 
qualitative studies on FND (e.g. [27, 28]) which describes some of the experiences of stigma 
encountered by people with FND. Qualitative research in health serves an incredibly 
important function of identifying and giving a platform to the voice of individual patients and 
professionals operating within this system. This research methodology often amplifies the 
voices of both those delivering services and those receiving services in a healthcare 
environment. In doing so, this type of research has a humanizing effect [29], giving service 
users an active voice in a sphere that affects them greatly. When considered relative to the 
negative and potentially dehumanizing effect of stigma, qualitative research itself may 
contribute to the opposition of stigma through this process of humanization. Furthermore, 
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reviews of qualitative research play an important role in healthcare and serve functions such 
as consolidating research on the lived experience of individuals and supporting practitioners 
[30] as well as influencing policy [31]. 
 
Consequently, the aim of the present review is to examine the unique experiences of stigma 
described by individuals in qualitative research to gain a greater understanding of the impact 
of stigma upon their experience which would inform the provision of better support. In doing 
so, the review proceeded with the broad research question; how do people with FND 
experience stigma?  
 
2. Method 
2.1 Database searches 
In consultation with two subject librarians, five databases were chosen for the search: 
PsycINFO, Web of Science, CINAHL, MEDLINE and EMBASE. These databases were 
chosen for their focus on health sciences research, psychology, healthcare and medicine. The 
search strategy sought to identify all of the qualitative papers available on FND. In doing so, 
it adopted qualitative research and FND as two core concepts. Both free text terms and 
subject headings were utilised which incorporated a variety of terms that have been used to 
describe FND. The specific FND terms were informed by previous reviews in the area [5, 18, 
32]. These terms were combined using the AND operator with a variety of subject headings 
and free text search terms to cover qualitative research methodologies. See Table 1 for a 
sample of the search run in PsycINFO. For the remaining databases, this was translated to use 




Searches were conducted in February 2021. A search strategy test was conducted whereby 
five known key papers relevant to the review were identified. All five papers were present in 
the search results indicating that the search strategy was effective in finding papers relevant 
to the review. 
 
Table 1 PsycINFO search 
 Search terms  
 FND terms 
(DE Somatization) OR (DE "Somatization Disorder") OR (DE 
"Somatoform Disorders") OR (DE "Conversion Disorder") OR (DE 
"Movement Disorders") OR "functional neurological disorder" OR 
pseudoseizure OR pseudo-seizure OR "functional movement disorder" 
OR NEAD OR PNES OR NES OR “attack disorder” OR nonepileptic 
OR non-epileptic OR “non 
epileptic” OR pseudoseizure* OR ((seizure* OR convulsion*) N3 
dissociative) OR ((seizure* OR convulsion*) N3 hysterical)  OR 
“pseudoepilep*” OR hysteroepilep* OR ((conversion OR psychogenic 
OR functional) N3 seizure*) OR ((conversion OR psychogenic OR 
functional) N3 paralysis) OR ((conversion OR psychogenic OR 
functional) N3 movement) OR FND OR “functional neurologic*” OR 
“functional movement” OR “functional motor” OR “functional N3 
paralysis” 
AND Qualitative research terms 
(DE "Qualitative Measures") OR (DE "Qualitative Methods") OR (DE 
"Focus Group") OR (DE "Focus Group Interview") OR (DE "Interview 
Schedules") OR (DE Interviewers) OR (DE Interviewing) OR (DE 
Interviews) OR (DE "Interpretative Phenomenological Analysis") OR 
(DE "Mixed Methods Research")  OR DE ("Grounded Theory") OR 
((personal OR patient OR subjective OR lived OR subjective) N3 
experience) OR interview OR qualitative OR “focus group” OR 
phenomenological OR “phenomenolog*” OR “conversation analysis” 
OR “thematic analysis” OR “discourse analysis” OR “grounded theory” 
OR “narrative analysis” OR “mixed method*” 
Note: DE is a psycINFO subject heading search term 
 
2.2 Inclusion Criteria 
Inclusion criteria for the review were: qualitative methodology used (defined as any method 
that involved participants’ descriptions of their lived experience); focused on the perspective 
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of individuals with an FND diagnosis; peer-reviewed and available in English. Furthermore, 
papers must have reported a theme or similar portion of text relevant to stigma. For the 
purpose of this review, any theme which detailed participants being treated differently to 
others, facing discrimination, or being treated in a way which prevented them from attaining 
full social acceptance due to their illness was deemed relevant.   
 
A total of 9,116 papers were identified from the databases searched. After duplicates were 
removed, 7,114 remained. The title and abstract of these papers were screened for relevance 
and 7,063 were removed at this stage. Following this, 51 full text papers were assessed for 
eligibility. Reference lists of these 51 papers were screened and one additional relevant paper 
was identified and assessed for eligibility. At this stage, 38 papers were excluded as they did 
not meet inclusion criteria. This left 13 papers remaining. See Fig. 1 for a PRISMA diagram 







































Records identified through 
database searching 



























Additional records identified 
through other sources 
(n =   1) 
Records after duplicates removed 
(n = 7113) 
Records screened 
(n =  7113 ) 
Records excluded 
(n =  7062 ) 
Full-text articles assessed 
for eligibility 
(n =  51 ) 
Full-text articles excluded 
(not peer-reviewed, not 
related to FND, did not 
focus on patient 
experience) 
(n = 38) 
Studies included in 
qualitative synthesis 
(n = 13) 
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Table 2 - Papers Included in the review 
Paper Aim Methodology Participants Data Collection Major Findings CASP 
Dosanjh et. al. 
(2020) [28] 
To gain insight into 
how individuals with 
FMD make sense of 







IPA 8 (FMD) Semi-structured 
interview 
Participants experiences of FMD had a 
significant impact on relationships with 
themselves and others. This in turn led to 
difficulties in well-being. 
22 





experience a change 
in diagnoses from 
epilepsy to FS. 
Interpretative 
analysis based on                     
systematic 
condensation 
10 (FS) In-depth interview The manner in which diagnosis is 
communicated can have an impact on how 
people understand and adjust to it. More 
cooperation between services such as 
neurology any psychiatry would bridge 
people’s needs and lead to less feelings of 
being abandoned. 
20 
Karterud et. al. 
(2015) [34] 
Explored the impact 
of using a 
biopsychosocial 
approach to explain 
FS diagnosis 
Interpretative 
analysis based on                     
systematic 
condensation 
11 (FS) Semi-structured 
interview 
Being believed was a key factor in coping with 
the condition. 
22 




managed by young 
people with an FS 
diagnosis 
Thematic analysis 11 (FS – aged 
14-24) 
Interview and follow 
up 
Discovered a relationship between the 
legitimacy of the illness that participants 
experienced and the extent to which they 
participated and recreated socially. Those with 
more meaningful illness perceptions engaged 
in more social participation. 
22 




children and families 
with FS. 
Thematic analysis 29 families 
10 young 
people (FS) 
Focus groups and 
telephone interviews 
Young people and families with experience of 
FS experience significant impairment. 
Pathways to diagnosis are unclear. Found that 
framing the diagnosis of FS as “good news” 
was not experienced positively by children and 
families. 
21 




Paper Aim Methodology Participants Data Collection Major Findings CASP 
Nielsen et. al. (2020) 
[37] 
Explored the 




11 (FMD) Semi-structured 
interviews 
Participants described a lack of understanding 
in their interactions with healthcare 
professionals. They experienced significant 
emotional and physical burden through their 
condition. Psychological explanations offered 
by professionals were not satisfactory. 
22 
Pretorius and 
Sparrow (2015) [38] 
Explored the 
experience of people 
in South Africa with 
an FS diagnosis 
Thematic analysis 10 (FS) Semi-structured 
interviews 
Described the challenges faced by people with 
a FS diagnosis and identified some resources 
that can act as a support. 
22 
Rawlings et. al. 
(2017) [39] 
Explored written 
accounts of people 
with an FS diagnosis 
Thematic Analysis 19 (FS) Written accounts – 
participants were 
asked to write; their 
thoughts and feelings 
about the condition, 
a letter to their 
condition, a letter to 
their younger selves 
and about their 
personal value  
Findings highlighted the stigma experienced 
by people with a diagnosis of FS.  
22 
Rawlings et. al. 
(2018) [27] 
Explored written 
accounts of people 
experiencing seizures 





Written accounts – 
participants were 
asked to write for 20 
minutes detailing 
their deepest 
thoughts and feelings 
about their condition 
Found a difference in narrative between those 
with epilepsy and those with FS. Noted that 
those with FS used a “feeling lost” typology 
when describing their illness. 
22 
Robson & Lian 
(2017) [40] 
Explored how people 
with FS experience 
healthcare 
encounters. 
Thematic analysis 135 (FS) Free-text survey 
responses 
Highlighted the negative experiences people 
with FS have in healthcare encounters. These 
were explored through a stigma framework 
21 
Sarudiansky et. al. 
(2017) [41] 
Explored the 
thoughts of people 
with an FS diagnosis 
in Buenos Aires, 
Argentina 
Thematic Analysis 5 (FS) Semi-structured 
interviews 
Found that these participants frequently 
adopted somatic frameworks to understand 




Paper Aim Methodology Participants Data Collection Major Findings CASP 
Thompson et. al. 
(2009) [42] 
Provided insight in to 
the experience of 
receiving a diagnosis 
of FS from a patient 
perspective 
IPA 8 (FS) Semi-structured 
interviews 
The results indicated that some patients 
experience distress when the diagnosis is 
communicated. An ability to integrate the 
diagnosis into a personal narrative was seen as 
beneficial.  
17 




receiving a diagnosis 
of FS and engaging 
in therapy following 
this 
Thematic analysis 6 (FS) Semi-structured 
interviews 
Highlighted the impact of receiving this 
diagnosis and how this can have a subsequent 
effect on how people engage with therapy. 
18 
Note: FMD – Functional Movement Disorder; FS – Functional Seizures, IPA – Interpretive Phenomenological Analysis; CASP – Critical Appraisal Skills Programme, 










2.3 Quality rating system 
The quality rating system used in this review was the Critical Appraisal Skills Program 
(CASP) qualitative research checklist [44]. This tool comprises ten questions designed to 
assess the quality of qualitative research. The first two questions act as screening questions to 
determine whether proceeding with the appraisal is worthwhile. The remaining eight 
questions were used to rate the quality of papers used in the review. In doing so, the three-
point rating system advocated by Duggleby et. al. [45] was utilized. This used the CASP 
questions and applied a score for each question. Scores ranged from a weak score (one point) 
for articles that did not explain or justify the issue being examined by the CASP question, a 
moderate score (two points) where the issue was mentioned but not expanded upon, or a 
strong score (three points) where the issue was both justified and sufficiently expanded upon. 
The scores from the eight items were added to give a total score for each article with a 
maximum possible score of 24. Using this system, the lead researcher and a peer reviewed 
the papers independently and reached a consensus on scores afterwards. Rating 
disagreements were discussed further in an effort to reach a consensus. Where this was not 
possible, the lead researcher had the final say on the score applied. Consequently, the papers 
achieved ratings that ranged from 16 to 22. While CASP scores were not used as inclusion or 
exclusion criteria, following the analysis the sources of each theme were checked to ensure 
that the higher quality papers were well-represented in the results and no theme depended 
solely on the weaker papers. 
 
2.4 Meta-ethnography approach 
 
The method adopted for this review was Noblit and Hare’s [46] seven-step method of meta-
ethnography. Stigma is a frequently recurring topic in the literature on functional seizures and 
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for many is a central part of their illness experience. While this has formed a part of many 
qualitative studies, this information has not yet been synthesized. A meta-ethnography 
approach allowed for this to be synthesised alongside the additional interpretations to provide 
a fuller understanding of this experience with a view to developing results that will inform 
practice [47]. This approach was suitable in investigating the conceptual and theoretical 
understandings of stigma towards this group, compared with other approaches to qualitative 
analysis that are more descriptive in nature [48]. The first two steps of “getting started” and 
“deciding what is relevant to the initial interest” are detailed in the introduction to the topic 
and the search strategy. Following this, the papers were read and coded line by line, notes 
were made of key concepts completing the “reading the studies” phase. Then, in the 
“determining how the studies are related” phase the codes were compared to identify 
relationships between the concepts covered in each study. After this, the “translating the 
studies into one another” phase involved translating the codes and themes together in order to 
develop an understanding of stigma. Following this, “synthesising translations” brought the 
translations together into themes that represented common translations and new 
interpretations. Finally, the synthesis was expressed through the writing of this paper. See 
appendix 1 - B for a demonstration of the process. 
 
2.5 Reflexivity 
Given the interpretative nature of this review, it should be recognised that researchers bring 
an a priori understanding of the topic at hand to the research process. Indeed, the researcher 
approached this meta synthesis as a trainee clinical psychologist having had direct encounters 
with people who have experience of FND in a research capacity. While this served as 
inspiration for the study, it also led to an expectation that stigma would be prevalent in the 
studies covered by the review. Furthermore, the researcher is a male from a white, Irish, 
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working class background. As a result, a professional, Western worldview may have 
influenced this synthesis. However, the potential impact of bias arising from this is somewhat 
mediated through the use of published research and systematic search methods. Furthermore, 
consulting with supervisors throughout the process of recognising and reporting the themes 




The review incorporated 13 qualitative papers. These studies included a total of 264 
participants with an FND diagnosis. Geographically, samples were recruited from the UK in 
7 papers, Norway for 3 papers and one each from South Africa and Argentina. A further 
paper [40] recruited internationally with the majority of participants living in the UK or 
North America. As a result, there is bias in the sample included towards White, Western 
countries. In terms of gender, where reported there was a majority of over 80% female 
participants across all of the studies. This is consistent with the epidemiological profile of 
FND [7]. 
 
The review identified four themes through which the synthesis of these papers can be 
expressed. These were: Delegitimization; excluded, isolated and abandoned – the social cost 
of stigma; the cost of attempts to manage stigma; and threats to identity and the meaning of 
mental health. These themes will be described in detail. 
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3.1 Theme 1. Delegitimization 
This theme reflects the experience of individuals across the studies whereby they were treated 
with less legitimacy than those with other illnesses and represents external stigma towards the 
individual. Delegitimization featured consistently in the accounts of participants across the 
papers in this review. In the descriptions provided by participants this experience was 
complex and wide ranging and included being dismissed by others, not being believed [27, 
28, 33-43] or of being left with the impression that their illness is less valid than one with a 
clear organic cause [28, 33, 34, 36, 39, 40, 42]. This experience was felt across a range of 
contexts including medical settings [28, 38, 40, 42], at work [35] and in education [35, 36]. 
 
The felt experience of delegitimization for many came in the form of not being believed [27, 
28, 33-43],  for example: “I was pretty much told that my condition didn’t really exist and 
that I was just hysterical and an attention seeker” [40 p. 7]. The lack of belief in the 
experience of participants’ symptoms was frequently accompanied by a level of judgement 
“[they] told me I am going crazy and I have conscious control over everything and nothing is 
wrong I am just lazy and go to the hospital frequently because I have nothing better to do [40 
p. 8].” For many participants the experience of not being believed was extended to situations 
where it was implied that they were feigning their symptoms [28, 33, 35, 39, 40, 43], 
encountering attitudes such as “either you are making it up or it isn’t a real condition [39 p. 
88].”  
 
Alongside disbelief, a degree of blame was present [28, 34, 37, 39-42]. It appeared that where 
the people and institutions in the lives of participants did not understand the condition, they 
blamed the person experiencing FND. At times it appeared that where a system could not 
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account for the experience of a person with FND, it led to that system rejecting the idea that 
the individual could possibly have that experience “Well none of it makes sense so you can’t 
be experiencing all these [28 p. 9].” 
 
Interactions with healthcare services served as a location for many delegitimizing experiences 
[27, 28, 33-40, 42, 43]. Participants spoke about their journeys towards a diagnosis which 
often took a significant amount of time [27, 28, 37-40, 42, 43] and then even when a 
diagnosis was given participants felt that medical professionals saw their condition as less 
valid than one with an identifiable organic cause. For example, a participant with a diagnosis 
of FS commented:  
One neurologist treated me like I wasn’t important because I didn’t really have epilepsy. He just 
wanted to push me onto another neurologist to get me out of his office. He didn’t really seemed to care 
about my feelings or what I had to say. I felt very ashamed walking out of his office, because I wasn’t a 
real epilepsy patient [40 p. 9].” 
Experiences of delegitimization were also experienced beyond healthcare and present 
throughout the lives of the participants. Individuals described similar attitudes in educational 
settings; “[a teacher] said that I played her just to get out of having a test and I faked having a 
fit [36 p. 132].” Further examples of this were found in the workplace [28, 35].  
 
On the other hand, there were a minority of occasions where individuals had a more positive 
experience [28, 34, 37, 38, 42, 43]. Where a sense of legitimacy was present, this changed the 
nature of interactions for the better. For instance, participants feeling believed and accepted 
by the professionals that they were encountering had a range of positive implications such as: 
“I’m thinking, ‘yes! yes! somebody believes me.’ It just made me feel . . . a genuine person 
 1-20 
[42 p. 511].” These examples appeared to be rare moments of legitimacy and understanding 
in a process where the predominant experience was one of being dismissed and 
delegitimized. For many participants it appeared that the experience of legitimacy was more 
frequent in closer personal relationships than in contact with professionals and institutions 
“At school and in working life, the participants said that they felt more respected and better 
understood by peers and friends than by teachers and employers [35 p. 25].” 
 
3.2 Theme 2. Excluded, isolated and abandoned – the social cost of stigma 
This theme relates to the social cost of stigma for participants. Whereas the previous theme 
highlighted the experience of being stigmatised by professionals, by having an illness that 
was appraised as invalid, this theme highlights the impact of this external stigma on the 
public lives of those affected. It describes the ways in which social forces act upon them in a 
stigmatizing fashion. Within this theme, participants gave descriptions of being abandoned, 
isolated and pushed to one side by friends and wider society. 
 
A loss of status or damage to their social role was a consequence of stigma in FND [28, 33, 
35, 36, 38, 40]. Participants spoke about losing their independence, friends and education 
[36]. While some participants spoke of the isolation experienced as they missed out on social 
relationships [42], a rejection from major social institutions was central to this experience. 
Other participants described a sense of subtle exclusion from normal activity whereby they 
were cushioned from harm to an extent but ultimately treated differently from their peers; “At 
school they still treat me like a little kid as well. They say you can't do this, you've got to be 
careful because you'll over exert yourself [36 p. 130].”  
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For many, the social cost of stigma came in the form of being abandoned by healthcare 
services [27, 28, 33-40, 42, 43] ‘‘I was discharged again without any explanation and just left 
[42 p. 511].” This left individuals feeling frustrated with services “refer me on! Do 
something. Don’t just allow me to stay at home and do nothing [37 p. 2046].” These 
difficulties in finding appropriate care were frequent with participants feeling that they were 
alone in managing the condition, that support was not available to them [27]. This feeling 
was very much present in the journey towards diagnosis that participants described as long 
and arduous [27, 28, 37-40, 42, 43]. It appeared that a lack of understanding on the part of 
healthcare played a role in participants’ experience here [27, 28, 33-39, 41-43]. Furthermore, 
a secondary cost of stigma was identified in that healthcare services often paid less attention 
to other non FND health concerns raised by participants meaning that participants’ other 
health concerns were ignored:  
“My GP blamed my ear and sinus pain on my condition, even though after prompting her to look in my 
ears she found that I had a sinus and ear infection [...] Even when visiting my dentist with tooth pain I 
was asked whether it could be due to clenching my jaw together when I am anxious! [40 p. 7]” 
 
Other participants experienced direct physical harm as a result of their FND diagnosis [38, 
40]. Participants spoke of dangerous situations where healthcare workers sought to prove that 
the condition was being feigned in some way: 
The nurse [...] put me in a wheelchair with force and started shouting at me and pushing my shoulder 
and head back into the chair. I was very woozy and didn’t understand what was happening. My body 
started to shake, my eyes were open so I was clearly awake, the nurse went to do the sternum rub and 
instead punched my collar bone and started to rub her knuckles hard on that, she then pushed the 
wheelchair back into the wall and my head hit. She threatened to call the mental health down and said 
that ‘she couldn’t watch me all night have a fit’ and that I was taking up everyone’s time and I was 
wasting the NHS resources and money [40 p. 9]. 
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Such instances indicate a clear breach of ethical practice and display how an experience of 
social stigma within an institution can manifest in direct physical harm. Indeed, situations 
where medical professionals appeared to act in these ways seemed to be underpinned by a 
lack of understanding. For example, when encountering a patient could not be understood, an 
assumption was made that the patient must be acting in a deceitful manner.  
 
Where participants encountered social systems that were supportive and inclusive, this 
appeared to act in the opposite fashion, helping them to adjust to their symptoms and 
diagnosis [33-35, 40]. The support of friends and family counteracted some of the effects of 
stigma in some cases [38]. 
 
3.3 Theme 3. The cost of attempts to manage stigma 
This theme related to the personal costs of stigma and represents individuals’ efforts to cope 
with external stigma. Often, participants were presented with a position where they had to 
manage stigma in addition to their illness. In these situations, participants seemed to respond 
by seeking to protect themselves against further harm. Where the theme above related to 
external social stigma, this theme captured some of the internal experiences triggered by 
stigma. 
 
In order to manage the stigma that they encountered, some participants sought to carry on as 
normal, as if they did not have FND symptoms [28, 35]. In doing so, participants wore 
themselves out “I felt exhausted from trying to continue to be normal [28 p. 9].” Similarly, 
controlling the information available to others about their FND symptoms was a key strategy.   
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“I was furious if they (the teachers) said something while I was away… (…) … I'll sue them for breach 
of confidentiality. I do not want to tell the teachers this … (…) Really, I want to say that they 
diagnosed epilepsy. [35 p. 25]” 
Telling people that they had epilepsy was a common strategy as this was more readily 
understood and felt less stigmatising for these participants [33, 35, 36]. This approach links 
with the idea in theme 1 whereby medical professionals and perhaps wider society have more 
familiarity with epilepsy as an organic disease and treat it in a less stigmatizing manner. 
 
Many participants resorted to self-isolation as a result of the stigma that they encountered 
[28, 35, 37, 38, 40, 42]. It appeared that individuals expected a degree of stigma in daily life 
and as a result avoided normal activity “I went out less. . . I just didn’t want to do anything 
that was going to embarrass me [28 p. 9].” In doing so, participants described withdrawing 
from social relationships [28] and work [35]. This avoidance of public situations extended to 
healthcare for fear of further adverse experiences and judgement;  
“I felt deeply misunderstood and offended and it has affected me hugely [...] I now have difficulty 
trusting healthcare professionals [...] I fear hospitals, almost to a phobic extent [...] It has affected me 
massively [...] when you don’t trust that you’ll be treated appropriately by others when completely 
unable to explain or defend yourself, it’s terrifying [...] I don’t think health professionals realise the 
potential consequences of their actions [40 p. 10].” 
Through this strategy, individuals often appeared to experience compounded difficulties as 
they did not receive appropriate healthcare as they did not seek it. Furthermore, this approach 
resulted in participants experiencing further exclusion “you hear less and less from people 




Underlying some of these actions were a variety of fears such as a fear of being judged [27, 
28, 33-36, 39-43] “if someone saw me what would they be thinking [28 p. 9]” and 
participants spoke widely of feeling that others were judging them in some way “I worry that 
they will think lots of negative things. They’ll think I’m a complete lunatic [34 p. 25].” It 
appeared that for some, the experience of stigma led to expectation of further judgement from 
others in many participants “They surely think that I am faking the seizures now as there is 
no organic reason for them [33 p. 42].” 
 
Again, participants described less frequent moments where they were treated with a degree of 
legitimacy and respect [28, 34, 36, 38, 42, 43], and this led them to feel that they could 
participate as normal in society.  
“I know I have seizures, and I know that I have problems. It has taken me a long time … But I'm happy 
that I have reached where I am today. When I get seizures in public…. I care… not. What happens, 
happens [35 p. 26].” 
Where this was the case, individuals appeared to arrive at this opinion after a significant 
period of adjustment [34 p. 42]. 
 
3.4 Theme 4. Threats to identity and the meaning of mental health 
This theme describes interactions that participants found particularly stigmatizing, where they 
were confronted with opinions and explanations for their difficulties that contrasted greatly 
with their view of themselves and the world. This theme represented a resistance to 
internalising stigma where it clashed with their core beliefs about themselves and others. 
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Many of the stigmatizing responses towards people experiencing FND appeared to cause 
particular discomfort and pain where they led to a perceived threat to the identity of the 
individual. For instance, where they were not believed as described above, participants 
highlighted the feeling that they had been judged as somebody who would set out to deceive 
others [27, 28, 36, 37, 40-42]. This was often accompanied by some implied judgement that 
they were in control of their symptoms or chose to have them. In turn, this led participants to 
feel that their identity was under attack e.g. “I do not want people to think I’m a bad person 
because I suffer from seizures [34 p. 110].” 
 
A significant threat to participants’ identity presented through the internalisation of blame 
[27, 28, 33-40, 42, 43]:“loser, just pull yourself together. [39 p. 87]” Participants described 
themselves as feeling “weak”, “useless”, “pathetic” and a “waste of space and money [39 p. 
87].” While the blame identified through theme 1 above was external and directed towards 
individuals, here the blame was internalised with participants blaming themselves for their 
difficulties and the impact that they have had on others “I feel guilty, I feel like, why do I 
have this? I made everyone feel angry and upset and I'm making the family fall apart [36 p. 
130].” Statements such as this appeared to show that participants felt a degree of self-blame 
for stress in their family caused by their symptoms and stigmatizing understandings about the 
degree of control that they held over them. Additionally, the experience of external stigma for 
some participants led to an internalisation of stigmatising ideas that their symptoms may not 
be real “Am I actually getting these symptoms or is it all in the head? [28 p. 9].” This sense 
of internalised blame for their difficulties often led to intense emotional experiences such as 
anger “I’d get right frustrated, start crying. . . chuck things and get right angry with meself. 
[28 p. 8].” 
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Across the studies, psychological explanations of FND appeared closely linked with notions 
of identity for individuals in the studies. For some, psychological explanations added to the 
sense of delegitimization discussed above (theme 1) “Because that’s what it feels like, 
psychological feels like it should mean, it’s literally you are making it up. It’s all in your 
head, there’s nothing wrong with you at all [36 p. 2046].” However, for many the description 
of experiencing a mental illness presented as a greater threat to their identity [28, 33-35, 37-
40, 43]. For example, a key concern for many individuals covered by the studies in this 
review related to being diagnosed with a mental health issue [28, 33-35, 37-40, 43]. Some 
participants completely rejected the idea of experiencing a mental health difficulty, seeing it 
as abnormal in some way, and expressed that such an explanation was a challenge to how 
they viewed themselves “I am normal and don’t have any mental health issues [39 p. 88].” 
Participants felt misunderstood when referred to psychology or psychiatry for support “I 
can’t see how talking to somebody is going to fix it [42 p. 510]”   
 
Some of the negative perspectives towards psychological explanations for FND came through 
healthcare interactions whereby they had been treated well until they had been diagnosed 
with a functional disorder implying psychological cause.  
Negative attitudes of HCPs towards what they perceived as psychogenic problems (i.e. having a 
psychological basis), may have played some role in the participants’ dissatisfaction with receiving 
psychological explanations for their problem. It was common for participants to describe experiences 
of poor treatment and negative interactions with HCPs only after a psychogenic diagnosis was made 
[37 p. 2046]. 
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This response to psychological explanations of their experience was not universal to 
participants across the studies. Contrasting with the threats to identity that some explanations 
resulted in, some participants highlighted the benefits of viewing their condition from this 
perspective [28, 34, 37, 41, 42]. For example, providing psychological explanations that 
recognised the interactions between life events and physical responses such as stress and the 
subsequent impact on FND symptoms appeared more acceptable to some with FND e.g.: 
It made a lot more sense when they explained what it was about in a little more depth. That it’s all 
about connecting links that trigger a seizure and that it comes from feelings and thoughts that you have. 
For example, if you are afraid . . . if you think too much that you’re afraid, then a seizure happens. So 
in that way you get a little more understanding of why seizures occur and what they really are. In 
comparison with just hearing that you have psychogenic non-epileptic seizures . . . so it was very useful 
(. . .) It is more about that it is stress reactions that trigger a seizure from the brain [34 p. 110]. 
Indeed, explanations that accounted for the individual experience and identity of the person 
experiencing FND appeared to be more readily acceptable. It appeared that these 
explanations recognised the complexity that the participants faced and sought to understand 
that as opposed to informing them that they are experiencing s psychological difficulty that 
they somehow should have control over [28, 34, 37, 41, 42].  
 
4. Discussion 
This systematic review provides the first synthesis of studies exploring the experience of 
stigma for people with FND. In doing so, it adds to the growing body of literature that overtly 
recognises stigma towards people with FND [6, 24]. For many people who receive a 
diagnosis of FND, stigma is a central part of their experience. The results of this review 
identify that this is experienced in all aspects of their lives from their own psychological 
experience to their interactions with wider society [19]. 
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Returning to Goffman’s [21] definition of stigma concerning the devaluation of social 
identity, the descriptions here show that people with an FND diagnosis experience this on a 
large scale. The theme of delegitimization described here represents a sense of being treated 
as “lesser than” or “less valid” than other people. Through this, a sense of “othering” creates 
distance and presents those with FND with a somehow less valid social identity, the effects of 
which are clearly visible in themes 2, 3 and 4 of this review. On top of this social experience, 
individuals described the phenomenon of internalised stigma whereby they have taken this 
message delivered by society and applied it to themselves, visible in themes 3 and 4. Indeed, 
participants identify clearly a sense of enacted or external (themes 1 and 2) and felt or 
internal (theme 3 and 4) stigma identified by Scambler and Hopkins [49]. Research into 
mental health stigma [50] has highlighted the additional impact of internalised stigma on 
symptom severity and treatment adherence, signalling the potential additional difficulty that 
this causes for those with FND symptoms. Additionally, a central tenet of the theory of 
stigma centres around a power imbalance. Indeed, Link and Phelan’s [22] theory on stigma in 
healthcare notes a power imbalance as a pillar without which stigma cannot operate. As can 
be seen in the experience of these participants, particularly in themes 1 and 2, stigma has 
arisen in traditional institutions where a power imbalance often exists – school, work and 
healthcare. 
 
Furthermore, the results of this review show how participants experience compounding 
difficulties as a result of the stigma they face. Link and Phelan [22] highlight how 
stigmatising experiences such as those described by participants are likely to affect their life 
chances through increased barriers to accessing appropriate education, employment and 
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healthcare. Indeed, difficulty accessing these have been noted in the FND population [7] and 
are described by the participants in this review in individuals’ difficulties maintaining their 
pre-illness life in the face of stigma around their condition.  
 
Additionally, the notion of stress in stigma creates a further challenge for individuals 
affected. As has been observed in theme 3, naturally, people make efforts to manage stigma 
such as carrying on regardless of the difficulties that they face or carefully managing the 
perceptions of others. This additional stress may act as an exacerbating factor making the 
original difficulties faced worse [22], another mechanism through which stigma exacerbates 
the difficulties faced by those experiencing FND. Indeed, this effect of stigma exacerbating 
psychological distress and causing additional damage through the erosion of social supports 
has been noted in the literature [51]. 
 
Considering the delegitimization that participants described in this review, a key factor 
underpinning this experience appears to be the view that FND is less valid due to the lack of 
established biomarkers for its diagnosis. The idea that healthcare has a positive bias towards 
conditions that can be observed and counted has been commented on in healthcare literature 
[52] identifying neoliberal ideals in health. This perspective encourages values in healthcare 
and society that promote an attitude of personal responsibility. This viewpoint disregards 
difficulties that cannot be clearly observed as a “disease of the will” [53] creating a belief that 
those who suffer from them have a degree of control over them. This preference for the 
physical and observable can be seen on a wider scale in the funding of services. For example, 
mental health services faced more cuts during the austerity era in the UK than their physical 
counterparts [54]. Indeed, the feelings of being abandoned expressed by individuals in this 
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review may relate to this lack of recognition of and subsequent provision for illness that is 
not socially accepted. Examples of this in this review were noted in the change in healthcare 
professional’s attitudes towards patients when they were deemed to be experiencing a mental 
health difficulty and in the views of participants not wishing to be viewed as being part of 
this stigmatized group.  
 
The above point links the results of this study with the experience of stigma faced more 
widely by people experiencing medically unexplained symptoms (MUS). Whilst MUS are 
more common that FND, a similar stigma towards people experiencing them exists due to the 
lack of a medical explanation [55]. Similar to FND, those with MUS have reported greater 
levels of perceived stigma compared to those with the corresponding medically explained 
diagnosis [56] which has been shown to have a negative impact on patient outcomes [57]. 
However, the experience of FND is distinct from MUS in the visibility of symptoms to 
others, which can attract a greater degree of external stigma. 
 
4.1 Clinical Implications 
This review identified stigmatizing interactions with healthcare professionals led people with 
FND to limit their contact with services. It has been well-documented that people 
experiencing FND often do not attend follow-up appointments, particularly with psychiatric 
services [56]. In these cases, addressing stigma would likely improve trust between services 
and those with FND and increase attendance at treatment. The results in this study compare 
with a review of practitioner experiences [25]. In the present review, participants reported 
feeling frequently misunderstood or dismissed leading to stigmatizing experiences. 
Interestingly, when practitioners spoke of their experiences, they reflected similar themes, 
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reporting feelings of being out of their depth, not understanding the presentation of FND 
[25]. The review of healthcare professionals identified the idea of a vicious cycle whereby 
individuals diagnosed with FND were passed from one service to the next without receiving 
an appropriate service. This closely matches participants’ descriptions of being abandoned by 
healthcare services. Thus, it may be that this lack of understanding or ability to provide 
support for FND patients presents practitioners with a degree of symbolic threat which leads 
to a stigmatizing response. Indeed, threat has been identified as a key process in the 
development of stigmatizing beliefs [57]. Therefore, increasing awareness and knowledge of 
FND is crucial in combatting stigma. Seeking to achieve this, recent research [58] has 
identified positive changes to practitioners’ views of FND following a training programme. 
Evidently, further training and education for healthcare practitioners is required in order to 
reduce stigma towards FND. 
 
Furthermore, for some people with an FND diagnosis, a coping style characterised by 
avoidance is core to their experience [32, 59]. Therefore, for this group encountering the 
attitudes outlined in themes 1 and 2 may compound this further, leading to the self-isolation 
and avoidance of services seen in theme 3. Due to the potential for an interaction between 
stigma and such coping styles to compound the difficulties of those experiencing FND, there 
is a clear clinical imperative to develop an early understanding of patient difficulties to 
support their adjustment and to prevent future disengagement due to stigma. 
 
The findings in this study are consistent with those frequently reported in studies on 
perceptions of people who experience mental health difficulties [60]. Participants in this 
review rejected the idea of experiencing a mental health difficulty, perhaps recognising the 
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stigma towards mental health difficulties that exist in society and do not wish to join this 
stigmatized group in the explanation of their own difficulties. However, it has widely been 
acknowledged that psychological factors play an important role in the development, 
maintenance and indeed treatment of FND for many [17]. Therefore, this raises the question: 
how can people with an FND diagnosis access explanations for their condition that 
incorporate important psychological factors without the associated stigma and threats to their 
identity? Some hints are to be found in the responses from participants in this review who 
identify the utility of explanations of the condition that connect with their unique experience 
and incorporate biological, psychological and social factors as has been advocated elsewhere 
[18]. Further research [61] has identified that the manner in which the diagnosis is explored 
can have an impact on how people adjust to the condition which in turn affects their 
prognosis. While there is evidence that psychological factors play a central role in 
understanding FND [17], this review highlights the need to provide psychologically informed 
explanations in a way that does not result in further stigma. 
 
4.2 Limitations 
A potential limitation of the literature which makes up this review is publication bias. As this 
review focused solely on peer-reviewed literature, it is possible that it failed to identify 
important concepts that have not been published. Furthermore, as noted in the results section, 
of the studies published on this topic, a large majority came from Western countries. Thus, 
the review was limited to the experience in these countries. 
 
In addition, all of the research that makes up the review has been led by clinicians and 
academics working in the area of FND research or clinical practice, as has this review. By its 
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very nature, qualitative research involves a level of active participation and interpretation on 
the researchers’ part. As a result, despite their focus on the experience of individuals with 
FND, in the process of research, this has been filtered through the perspectives of researchers 
and clinicians who form part of the institutions through which stigma towards this population 
has been perpetuated. In future research it may be beneficial to seek greater involvement 
from those affected by the issues covered in this review in the process of design, and analysis 
of research in this area.  
 
A further limitation of the review process was the use of a sole researcher for much of the 
project. However, the review did make use of a peer in the quality rating of papers. 
Additionally, the themes developed were discussed in detail in supervision throughout the 
study. 
 
4.3 Future research 
The presence of stigma throughout the studies reviewed here shows that stigma is a central 
concern for people with a diagnosis of FND. While research is currently focused on 
developing further understanding of the neurobiological and psychological features of the 
difficulty [17, 18, 62], this review highlights a key social aspect of the condition. While there 
is no specific evidence that stigma plays a causal role in FND, through its actions on those 
with the condition and the efforts made to cope with the associated judgement and distress, 
stigma may form a key part of understanding the condition. Despite the descriptions of 
stigma in the papers in this review, only one had an explicit focus on stigma. Therefore, 
further qualitative research into the stigma experienced by this group is warranted.  
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Furthermore, given the impact that stigma has on the lives of individuals affected by it, 
further research is required in this field to address stigma towards people with FND. Research 
investigating the efficacy of initiatives designed to reduce stigma would be useful to tackle 
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Appendix 1 – A - Table of CASP scores 
 










Findings Value of 
Research 
Total Score 
Dosanjh et. al. 
(2020) [28] 
3 3 3 2 3 3 3 2 22 
Karterud et. 
al. (2010) [33] 
2 3 3 1 2 3 3 2 20 
Karterud et. 
al. (2015) [34] 
3 3 3 1 3 3 3 3 22 
Karterud e. al. 
(2016) [35] 
2 3 3 2 3 3 3 3 22 
McWilliams 
et. al. (2016) 
[36] 
2 3 3 1 3 3 3 3 21 
Nielsen et. al. 
(2020) [37] 




2 3 3 3 3 2 3 3 22 
Rawlings et. 
al. (2017) [39] 
3 3 3 2 2 3 3 3 22 
Rawlings et. 
al. (2018) [27] 




3 3 2 2 3 3 3 3 22 
Sarudiansky 
et. al. (2017) 
[41] 
2 3 3 2 3 3 3 2 21 
Thompson et. 
al. (2009) [42] 
2 3 2 2 1 2 3 2 17 
Wyatt et. al. 
(2014) [43] 
2 3 2 1 3 2 3 2 18 
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Appendix 1 - B Sample of meta-ethnography process 
Theme Translation Code Papers 
Delegitimization Dismissed, less valid Nothing can be wrong with you Dosanjh et. al. (2020), Pretorius & Sparrow 
(2015), Robson & Lian (2017), Nielsen 
(2020) 
  Not believed Dosanjh et. al. (2020), Karterud et. al. 
(2010), Karterud et. al. (2015), Karterud et. 
al. (2016), McWilliams et. al. (2016), 
Nielsen et. al. (2020), Pretorius & Sparrow 
(2015), Rawlings et. al. (2017), Rawlings et. 
al. (2018), Robson & Lian (2017), 
Sarudiansky et. al. (2017), Thompson et. al. 
(2009), Wyatt et. al. (2014). 
  Not listened to Dosanjh et. al. (2020), Robson & Lian 
(2017), Wyatt (2014) 
  Dismissing medical interactions Dosanjh et. al. (2020), Pretorius & Sparrow 
(2015), Robson & Lian (2017), Thompson 
et. al. (2009) 
  Dismissing school interaction Karterud et. al. (2016), McWilliams et. al. 
(2016) 
  Dismissed in the workplace Karterud et. al. (2016) 
 It’s under your control – feigning and blame Making it up Dosanjh et. al. (2020), Karterud et. al. 
(2010), Karterud (2016), Rawlings (2017), 
Robson & Lian (2017), Wyatt (2014) 
  Being blamed Dosanjh et. al. (2020), Karterud et. al. 
(2015), Neilsen et. al. (2020), Rawlings et. 
al. (2017), Robson & Lian (2017), 
Sarudiansky et. al. (2017), Thompson et. al. 
(2009),  
 Less than organic Not organic – not valid Dosanjh et. al. (2020), Karterud et. al. 
(2010), Karterud et. al. (2015), McWilliams 
et. al. (2016), Rawlings (2017), Robson & 
Lian (2017), Thompson et. al. (2009) 
 Refutations Opposite of dismissed Dosanjh et. al. (2020) 
  Positive diagnosis Dosanjh et. al. (2020), Karterud (2015) 
  Believed Dosanjh (2020), Karterud et. al. (2015), 
Nielsen et. al. (2020), Pretorius & Sparrow 
(2015), Thompson et. al. (2009), Wyatt 
(2014) 
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Theme Translation Code Papers 
Excluded, Isolated, abandoned – the social 
cost of stigma 
Journey to treatment, what treatment? Seeking answers Dosanjh (2020), Nielsen et. al. (2020) 
Pretorious & Sparrow (2015), Rawlings 
(2017), Rawlings (2018), Robson & Lian 
(2017), Thompson et. al. (2009), Wyatt et. 
al. (2014) 
  No knowledge or understanding Dosanjh et. al. (2020), Karterud et. al. 
(2010), Karterud et. al., Karterud et. al. 
(2016), McWilliams et. al. (2016), Nielsen 
et. al. (2020), Pretorius & Sparrow (2015), 
Rawlings et. al. (2017), Rawlings et. al. 
(2018), Robson & Lian (2017), Sarudiansky 
et. al. (2017), Thompson et. al. (2009), 
Wyatt et. al. (2014). 
  Abandoned by healthcare Dosanjh et. al. (2020), Karterud et. al. 
(2010), Karterud et. al. (2015), Karterud et. 
al. (2016), McWilliams et. al. (2016), 
Nielsen et. al. (2020), Pretorius & Sparrow 
(2015), Rawlings et. al. (2017), Rawlings et. 
al. (2018), Robson & Lian (2017), 
Thompson et. al. (2009), Wyatt et. al. 
(2014). 
 Loss of status Demoted & rejected in the workplace Dosanjh et. al. (2020), Karterud (2010) 
  Role change Dosanjh et. al. (2020), Karterud (2016) 
McWilliams et. al. (2016), Robson & Lian 
(2017), Pretorius & Sparrow (2015) 
Thompson et. al. (2009) 
  Loss of independence Dosanjh et. al. (2020), McWilliams et. al. 
(2016), Pretorius & sparrow (2015), 
Thompson et. al. (2009) 
 Excluded and isolated Social exclusion Karterud (2016), McWilliams et. al. (2016), 
Nielsen (2020), Pretorius & Sparrow (2015), 
Rawlings (2018), Robson & Lian (2017), 
Thompson et. al. (2009),  
  Relationship strain Dosanjh (2020), McWilliams (2016), 
Nielsen et. al. (2020) 
 Physical harm and unethical treatment Conflict Dosanjh et. al. (2020), Nielsen et. al. (2020), 
Sarudiansky et. al. (2017),  
  Physical harm & attempts to find feigning Robson & Lian (2017), Pretorius & Sparrow 
(2015) 
 Refutations Understanding (rare occasions) Karterud et. al. (2010), Karterud et. al. 




Theme Translation Code Papers 
The costs of attempts to manage stigma Masking and seeking legitimacy Carry on as normal and conceal the 
diagnosis 
Dosanjh et. al. (2020), Karterud (2016) 
  Control information/pretend its epilepsy Karterud (2010), Karterud (2016), 
McWilliams (2016) 
 Avoiding and withdrawing Self-isolate Dosanjh et. al. (2020), Karterud (2016), 
Nielsen et. al. (2020), Pretorius & Sparrow 
(2015), Robson & Lian (2017), Thompson 
et. al. (2009). 
  Avoid healthcare and mistrust Karterud (2010), Robson & Lian (2017), 
Wyatt et. al. (2014) 
 Beliefs about belief Perceived judgement Dosanjh et. al. (2020), Karterud et. al. 
(2010), Karterud et. al. (2015), Karterud et. 
al. (2016), McWilliams et. al. (2016), 
Rawlings et. al. (2017), Rawlings et. al. 
(2018), Robson & Lian (2017), Sarudiansky 
et. al. (2017), Thompson et. al. (2009), 
Wyatt et. al. (2014). 
  Fear reaction of others Dosanjh et. al. (2020), Karterud et. al. 
(2010), Karterud et. al. (2015), Karterud et. 
al. (2016), McWilliams et. al. (2016), 
Rawlings et. al. (2017), Rawlings et. al. 
(2018), Robson & Lian (2017), Sarudiansky 
et. al. (2017), Thompson et. al. (2009), 
Wyatt et. al. (2014). 
 Refutations Connection & legitimacy leading to 
participation 
Dosanjh et. al. (2020), Karterud et. al. 
(2015), Karterud et. al. (2016), Pretorius & 
Sparrow (2017), Thompson et. al. (2009), 








Theme Translation Code Papers 
Threats to identity and the meaning of 
mental health 
Seizures mean I’m a bad person  Nothing medically wrong with you, what is 
the problem? 
Dosanjh et. al. (2020), Rawlings et. al. 
(2018), McWilliams et. al. (2016), Nielsen 
et. al. (2020), Sarudiansky et. al. (2017) 
Robson & Lian (2017), Thompson et. al. 
(2009) 
  Dishonest/attention seeker Karterud et. al. (2016), McWilliams et. al. 
(2016) Nielsen et. al. (2020), Rawlings 
(2017), Robson & Lian (2017),  
 Internalised blame and stigma Self-blame/Am I making this up? Dosanjh et. al. (2020), Karterud et. al. 
(2010), Karterud et. al. (2015), Karterud et. 
al. (2016), McWilliams et. al. (2016), 
Nielsen et. al. (2020), Pretorius & Sparrow 
(2015), Rawlings et. al. (2017), Rawlings et. 
al. (2018), Robson & Lian (2017), 
Thompson et. al. (2009), Wyatt et. al. 
(2014). 
 “I’m not crazy” – mixed responses to 
psychological explanations 
Not mental illness Dosanjh et. al. (2020), Karterud et. al. 
(2010), Karterud et. al. (2015), Karterud et. 
al. (2016), Nielsen et. al. (2020), Pretorius & 
Sparrow (2015), Rawlings et. al. (2017), 
Robson & Lian (2017), Wyatt et. al. (2014). 
  Psychogenic implying control Dosanjh et. al. (2020), Karterud et. al. 
(2010), Karterud et. al. (2015), Karterud et. 
al. (2016), Nielsen et. al. (2020), Pretorius & 
Sparrow (2015), Rawlings et. al. (2017), 
Robson & Lian (2017), Wyatt et. al. (2014). 
 Refutations Meaningful understanding Dosanjh et. al. (2020),Karterud et. al. (2015), 
Nielsen et. al. (2020), Sarudiansky et. al. 
(2017), Thompson et. al. (2009) 
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Appendix 1 - D CASP Checklist 
 
 
CASP Checklist: 10 questions to help you make sense of a Qualitative research 
How to use this appraisal tool: Three broad issues need to be considered when appraising a 
qualitative study: 
  Are the results of the study valid? (Section A) 
  What are the results? (Section B) 
  Will the results help locally? (Section C) 
The 10 questions on the following pages are designed to help you think about these issues 
systematically. The first two questions are screening questions and can be answered quickly. 
If the answer to both is yes , it is worth proceeding with the remaining questions  There is 
some degree of overlap between the questions, you are asked to record a yes , no  or 
can t tell  to most of the questions  A number of italicised prompts are given after each 
question. These are designed to remind you why the question is important. Record your 
reasons for your answers in the spaces provided. 
About: These checklists were designed to be used as educational pedagogic tools, as part of a 
workshop setting, therefore we do not suggest a scoring system. The core CASP checklists 
randomised controlled trial  systematic review  were based on JAMA Users  guides to the 
medical literature 1994 (adapted from Guyatt GH, Sackett DL, and Cook DJ), and piloted with 
health care practitioners. 
For each new checklist, a group of experts were assembled to develop and pilot the checklist 
and the workshop format with which it would be used. Over the years overall adjustments 
have been made to the format, but a recent survey of checklist users reiterated that the basic 
format continues to be useful and appropriate. 
Referencing: we recommend using the Harvard style citation, i.e.: Critical Appraisal Skills 
Programme (2018). CASP (insert name of checklist i.e. Qualitative) Checklist. [online] Available 
at:  URL. Accessed: Date Accessed. 
©CASP this work is licensed under the Creative Commons Attribution  Non-Commercial-
Share A like. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-
sa/3.0/ www.casp-uk.net  
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 Search terms  
 FND terms 
(DE Somatization) OR (DE "Somatization Disorder") OR (DE "Somatoform 
Disorders") OR (DE "Conversion Disorder") OR (DE "Movement Disorders") 
OR "functional neurological disorder" OR pseudoseizure OR pseudo-seizure 
OR "functional movement disorder" OR NEAD OR PNES OR NES OR “attack 
disorder” OR nonepileptic OR non-epileptic OR “non 
epileptic” OR pseudoseizure* OR ((seizure* OR convulsion*) N3 dissociative) 
OR ((seizure* OR convulsion*) N3 hysterical)  OR “pseudoepilep*” OR 
hysteroepilep* OR ((conversion OR psychogenic OR functional) N3 seizure*) 
OR ((conversion OR psychogenic OR functional) N3 paralysis) OR 
((conversion OR psychogenic OR functional) N3 movement) OR FND OR 
“functional neurologic*” OR “functional movement” OR “functional motor” 
OR “functional N3 paralysis” 
AND Qualitative research terms 
(DE "Qualitative Measures") OR (DE "Qualitative Methods") OR (DE "Focus 
Group") OR (DE "Focus Group Interview") OR (DE "Interview Schedules") OR 
(DE Interviewers) OR (DE Interviewing) OR (DE Interviews) OR (DE 
"Interpretative Phenomenological Analysis") OR (DE "Mixed Methods 
Research")  OR DE ("Grounded Theory") OR ((personal OR patient OR 
subjective OR lived OR subjective) N3 experience) OR interview OR 
qualitative OR “focus group” OR phenomenological OR “phenomenolog*” OR 
“conversation analysis” OR “thematic analysis” OR “discourse analysis” OR 
“grounded theory” OR “narrative analysis” OR “mixed method*” 
Note: DE is a psycINFO subject heading search term 
 
 
Web of Science 
 
 Search terms  
 FND terms 
Somatization OR "Somatization Disorder" OR "Somatoform Disorders" OR 
"Conversion Disorder" OR "Movement Disorders" OR "functional neurological 
disorder" OR pseudoseizure OR pseudo-seizure OR "functional movement 
disorder" OR NEAD OR PNES OR NES OR “attack disorder” OR nonepileptic 
OR non-epileptic OR “non 
epileptic” OR pseudoseizure* OR ((seizure* OR convulsion*) NEAR/3 
dissociative) OR ((seizure* OR convulsion*) NEAR/3 hysterical)  OR 
“pseudoepilep*” OR hysteroepilep* OR ((conversion OR psychogenic OR 
functional) NEAR/3 seizure*) OR ((conversion OR psychogenic OR functional) 
NEAR/3 paralysis) OR ((conversion OR psychogenic OR functional) NEAR/3 
movement) OR FND OR “functional neurologic*” OR “functional movement” 
OR “functional motor” OR “functional NEAR/3 paralysis” 
AND Qualitative research terms 
"qualitative measures" OR "qualitative methods" OR "focus group" OR "focus 
group interview" OR "interview schedules" OR "interviewers" OR 
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"interviewing" OR "interviews" OR "interpretative phenomenological analysis" 
OR "grounded theory" OR ((personal OR patient OR subjective OR lived OR 
subjective) N3 experience) OR interview OR qualitative OR “focus group” OR 
phenomenological OR “phenomenolog*” OR “conversation analysis” OR 
“thematic analysis” OR “discourse analysis” OR “grounded theory” OR 






 Search terms  
 FND terms 
MH "Somatoform Disorders" OR MH "Movement Disorders" OR "functional 
neurological disorder" OR pseudoseizure OR pseudo-seizure OR "functional 
movement disorder" OR NEAD OR PNES OR NES OR “attack disorder” OR 
nonepileptic OR non-epileptic OR “non epileptic” OR pseudoseizure* OR 
((seizure* OR convulsion*) N3 dissociative) OR ((seizure* OR convulsion*) 
N3 hysterical)  OR “pseudoepilep*” OR hysteroepilep* OR ((conversion OR 
psychogenic OR functional) N3 seizure*) OR ((conversion OR psychogenic OR 
functional) N3 paralysis) OR ((conversion OR psychogenic OR functional) N3 
movement) OR FND OR “functional neurologic*” OR “functional movement” 
OR “functional motor” OR “functional N3 paralysis” 
AND Qualitative research terms 
MH “Qualitative Studies” OR MH "Phenomenology" OR MH "Focus Groups" 
OR MH "Focus Groups" OR MH "Semi-Structured Interview" OR MH 
"Unstructured Interview" OR MH "Interview Guides" OR MH "Unstructured 
Interview Guides" OR MH "Structured Interview Guides" OR MH "Interviews" 
OR MH "Unstructured Interview" OR MH "Semi-Structured Interview" OR 
MH "Structured Questionnaires" OR MH “Thematic Analysis” OR MH 
"Phenomenological Research" OR MH "Phenomenology" OR MH “Grounded 
Theory” OR “experience” OR ((personal OR patient OR subjective OR lived 
OR subjective) N3 experience) OR interview OR qualitative OR “focus group” 
OR phenomenological OR “phenomenolog*” OR “conversation analysis” OR 
“thematic analysis” OR “discourse analysis” OR “grounded theory” OR 
“narrative analysis” OR “mixed method*” 





 Search terms (boolean) 
 FND terms 
MH "Somatoform Disorders" OR MH "Movement Disorders" OR MH 
"Conversion Disorder" OR MH "Movement Disorders" OR "non-epileptic" OR 
"functional neurological disorder" OR pseudoseizure OR pseudo-seizure OR 
"functional neurological disorder" OR pseudoseizure OR pseudo-seizure OR 
"functional movement disorder" OR NEAD OR PNES OR NES OR “attack 
disorder” OR nonepileptic OR non-epileptic OR “non 
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epileptic” OR pseudoseizure* OR ((seizure* OR convulsion*) N3 dissociative) 
OR ((seizure* OR convulsion*) N3 hysterical)  OR “pseudoepilep*” OR 
hysteroepilep* OR ((conversion OR psychogenic OR functional) N3 seizure*) 
OR ((conversion OR psychogenic OR functional) N3 paralysis) OR 
((conversion OR psychogenic OR functional) N3 movement) OR FND OR 
“functional neurologic*” OR “functional movement” OR “functional motor” 
OR “functional N3 paralysis” 
AND Qualitative research terms 
MH "Qualitative Research" OR MH "Focus Groups" OR MH "Interviews as 
topic" OR MH "Grounded Theory" OR MH Personal Narratives as Topic” OR 
((personal OR patient OR subjective OR lived OR subjective) N3 experience) 
OR interview OR qualitative OR “focus group” OR phenomenological OR 
“phenomenolog*” OR “conversation analysis” OR “thematic analysis” OR 
“discourse analysis” OR “grounded theory” OR “narrative analysis” OR “mixed 
method*” 






 Search terms  
 FND terms 
Psychogenic nonepileptic seizure/ OR somatoform disorder/ OR conversion 
disorder/ OR somatization/ OR "functional neurological disorder" OR 
pseudoseizure OR pseudo-seizure OR "functional movement disorder" OR 
NEAD OR PNES OR NES OR “attack disorder” OR nonepileptic OR non-
epileptic OR “non epileptic” OR pseudoseizure* OR ((seizure* OR 
convulsion*) NEAR/3 dissociative) OR ((seizure* OR convulsion*) NEAR/3 
hysterical)  OR “pseudoepilep*” OR hysteroepilep* OR ((conversion OR 
psychogenic OR functional) NEAR/3 seizure*) OR ((conversion OR 
psychogenic OR functional) NEAR/3 paralysis) OR ((conversion OR 
psychogenic OR functional) NEAR/3 movement) OR FND OR “functional 
neurologic*” OR “functional movement” OR “functional motor” OR 
“functional NEAR/3 paralysis” 
AND Qualitative research terms 
Qualitative analysis/ OR qualitative research/ OR interview/ OR semi structured 
interview/ OR structured interview/ OR telephone interview/ OR psychological 
interview/ OR unstructured interview/ OR phenomenology/ OR grounded 
theory/ OR ((personal OR patient OR subjective OR lived OR subjective) N3 
experience) OR interview OR qualitative OR “focus group” OR 
phenomenological OR “phenomenolog*” OR “conversation analysis” OR 
“thematic analysis” OR “discourse analysis” OR “grounded theory” OR 
“narrative analysis” OR “mixed method*” 
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Abstract 
This study used a single case experimental design incorporating both quantitative and 
qualitative data to assess the effect of mindfulness training delivered through a smartphone 
app for people experiencing functional seizures (FS). Four participants completed the study 
while one further participant completed it in part. Qualitative analysis identified that 
participants found an app-delivered intervention to be acceptable. Reliable and clinically 
significant changes were observed on outcome measures of seizure frequency, quality of life, 
psychological distress and a process measure of experiential avoidance for two participants 
and reliable and clinically significant improvements in mindfulness were observed in three 
participants. Similar benefits were not observed in the remaining participants indicating that 
this intervention may be suitable for some but not all people experiencing FS. Improvements 
in experiential avoidance appeared to be a key process for those who benefitted from this 
intervention. The implications of these findings for clinical practice and future research are 
discussed. 
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1. Introduction 
1.1 Functional Seizures 
Functional Seizures (FS) are events that present in a similar fashion to seizures caused by 
epilepsy. However, FS do not have the same corresponding electrical brain activity seen in 
epileptic seizures. The difficulty in identifying an organic cause has led to some alternative 
names for FS – Non-Epileptic Attack Disorder (NEAD) or Psychogenic Nonepileptic 
Seizures (PNES). FS has been proposed as a term that does not confer the same level of 
stigma as other terms and is a term widely understood by professionals [1] and has been 
adopted by advocacy groups such as FND Hope [2]. Thus, the term FS has been used 
throughout this paper. 
 
FS can be distressing for individuals who experience them as well as their families. They can 
be a source of significant burden [3] and impact upon people’s ability to live their lives as 
intended, interfering with their ability to work [4], and placing a strain on social relationships 
[3]. Indeed, research has shown that FS have a greater impact on quality of life than epilepsy 
[5]. It is estimated that FS affect between two to 33 per 100,000 population [6]; another 
estimate measured an incidence rate of 4.9/100,000 per year [7]. By either measure, FS is a 
frequently occurring neurological condition and it is estimated that 20% of people presenting 
to epilepsy clinics later receive a diagnosis of FS [8]. 
 
In addition to the individual burden of FS, there is a societal impact in the form of healthcare 
costs as people with FS frequently present to health services seeking support [9, 10]. 
Diagnosis of this condition is often delayed, with one study identifying an average wait of 7.2 
years [11]. This may lead to additional healthcare service utilization while awaiting a 
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diagnosis. The lack of appropriate treatment options for people with FS may play a role here, 
with people with FS returning to health services in times of crisis to seek further support. 
Many people with FS also report difficult interactions with healthcare services such as 
healthcare workers showing a lack of understanding or disbelief of their symptoms [3]. 
 
1.2  Present understandings of FS 
 
At present, no single explanatory model exists for FS. While risk factors have been identified 
for FS, these are not present for all individuals that experience FS. For instance, 
psychological trauma [15] is central to FS for some but not all. Similarly, FS 
disproportionately affects females and people who live in areas characterised by high levels 
of socioeconomic deprivation [16] though neither play a causative role in the aetiology of FS. 
While risk factors and characteristics go some way to describing those who experience FS, no 
aetiology has been developed to describe all cases of FS. 
 
For this reason, a biopsychosocial approach to FS has been proposed by some such as Baslet 
[17]. This model highlights predisposing factors such as trauma and adverse experiences, 
precipitating factors including stress combined with vulnerabilities such as avoidance 
tendencies and difficulty with emotional regulation. The perpetuating factors in this model 
include comorbid conditions further compounded by experiences such as chronic stress. 
 
In a similar vein, an integrative cognitive model has recently been proposed by Brown and 
Reuber [15]. In this model, Brown and Reuber [15] identified four existing concepts that they 
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sought to integrate. These included FS as the activation of dissociated material, FS as a hard-
wired behavioural response to events, FS as a physical manifestation of emotional distress 
and FS as learned behaviour. At its core, the model proposes a “seizure scaffold” described as 
a mental representation of seizures which, when activated by internal or external cues 
combined with a compromise in inhibitory functioning caused by chronic stress or other 
factors, results in a seizure. Additionally, the model recognises the varied pathways through 
which people develop FS. In doing so, it seeks to accommodate research on FS from a variety 
of perspectives and also recognise the variety of people that develop FS.  
 
1.3 Psychological Treatments for FS 
Despite the interest in this condition over such a long period of time, and models that indicate 
a psychological basis, research on effective psychological treatments is in its early stages. A 
recent meta-analysis [18] made the case for psychotherapy, highlighting that upon 
completion of therapy, 82% of participants showed a reduction in seizure frequency of over 
50%. However, of the 13 studies included in the review, 11 were assessed as having a strong 
risk of bias. Moreover, the use of papers with this level of bias is an indication of the lack of 
available high quality research in this area which has been noted in a previous critical review 
[19]. 
 
However, research in this area has been progressing. For example, there has been increased 
interest in the application of cognitive behavioural therapy (CBT) to FS and a number of 
randomized controlled trials (RCTs) [20, 21] have shown promising results leading to 
significant reductions in seizure frequency and benefits such as improved quality of life. 
However, a recent larger scale RCT investigating CBT for FS [22] found that while this 
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treatment brought benefits to quality of life and psychological distress, it did not lead to a 
significant improvement in seizure frequency compared to standard medical care.  
 
1.4 Third-wave approaches and mindfulness 
Third-wave cognitive therapies such as mindfulness-based therapies and acceptance and 
commitment therapy (ACT) place an emphasis on individuals’ relationships with their 
thoughts and emotions rather than on their content [23]. A position paper [24] highlighted the 
benefits that third-wave cognitive therapies could bring to people experiencing FS. In doing 
so it hypothesised that mindfulness may be useful in countering experiential avoidance – the 
avoidance of difficult thoughts and emotions - and in building psychological flexibility – the 
ability to remain fully present in the moment, allowing one to act in a way which reflects 
one’s own values [25]. Further empirical research has highlighted a higher prevalence of 
psychological inflexibility and experiential avoidance in FS compared to other populations 
[26], suggesting that interventions focusing on this could be beneficial. Building on this, 
intervention studies based on third wave approaches are just beginning – for example a recent 
single case experimental design (SCED) study [27] showed the benefits of an ACT 
intervention for FS. Four out of six participants in this study reported that they found the 
mindfulness aspect of this intervention particularly influential in the change they 
experienced. 
 
Mindfulness practice is an element of all third wave therapy models which involves 
developing the ability to pay attention to the present moment in a non-judgemental way. 
Mindfulness has a growing evidence base for a range of mental [28] and physical [29, 30] 
health conditions, including epilepsy [31]. However, less empirical research is available on 
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the processes through which mindfulness achieves these benefits. Nonetheless, a number of 
processes have been proposed such as increasing body awareness, improving people’s ability 
to regulate attention, changing people’s perspective of themselves and improving emotional 
regulation through exposure, reappraisal and reconsolidation [32]. Through these processes, it 
has been hypothesised that less useful strategies such as experiential avoidance become less 
automatic [33] giving people more choice around their reactions to internal and external 
events. 
 
Considering mindfulness processes in light of the model proposed by Brown and Reuber 
[15], we may hypothesise that practising mindfulness could give people with FS greater 
control over the activation of the seizure scaffold schema. Similarly, linking with Baslet’s 
model [34], the effect of mindfulness on precipitating factors including stress may provide 
benefits to those living with FS. Furthermore, as noted above, experiential avoidance plays a 
role in FS for many [26] and has been shown to improve with mindfulness practice [35]. In 
fact, a little empirical evidence exists indicating the possible benefits of mindfulness-based 
interventions for FS. For instance, a recent study [36] investigated the effects of individual 
mindfulness-based therapy delivered face-to-face. This study showed an improvement in 
seizure frequency and quality of life for participants who completed the intervention. 
However, the study noted that potential participants could not take part due to difficulties 
with transport arrangements, and a further 23 out of a total of 49 participants did not 
complete the intervention with a number of these participants citing difficulty attending 
appointments as a reason for dropping out of the study. 
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In addition to the above study, research has found high dropout rates from psychological and 
psychiatric interventions for people with FS. For example, a study examining adherence to 
psychiatric treatment found that only 17% of those referred attended the fourth of four 
appointments offered [37]. Additionally, high drop-out rates have been noted in an RCT 
study investigating CBT for FS where only 56% of participants attended all 12 sessions 
offered [22]. Despite these observations, little is known about the reasons why completion 
rates are so low. However, one reason as suggested above relates to physical barriers to travel 
to treatment centres. In this vein, a study investigated telehealth to support people with FS to 
access psychotherapy [38] and saw a completion rate of 84%.  
 
Alongside recent developments in technology, numerous efforts have been made to deliver 
psychological treatments remotely through the use of smartphones. Mindfulness training 
programmes delivered in this fashion have been shown to improve wellbeing [39]. 
Furthermore, in the context of the covid-19 pandemic, the importance of remotely delivered 
healthcare has come to the fore. 
 
Additionally, given the variety of presentations and maintaining factors proposed by the 
integrative cognitive model [15], it is important to identify further treatments to ensure that 
psychological treatments offered to individuals presenting with FS can be matched to their 
unique situation.  
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1.5 Aims 
Consequently, the purpose of this study was to evaluate the effectiveness and acceptability of 
a mindfulness-based intervention for people experiencing FS delivered via smartphone app. 
A case series based on SCED was chosen to investigate this. The primary aims of the study 
were to investigate whether such an intervention would lead to reduction in the frequency of 
seizures and improvement in quality of life among this group. Furthermore, the study aimed 
to assess the impact of the intervention on the process measures of experiential avoidance and 
mindfulness. Finally, the research aimed to gain an insight into the experience of people who 
used this intervention to determine its acceptability among this group and to assess its 
strengths and weaknesses from the participants’ perspective. 
 
Therefore, the research questions in this study were; (i) what effect does a mindfulness 
training app intervention have on the quality of life of people experiencing FS? (ii) Does a 
mindfulness training app intervention reduce seizure frequency in people experiencing FS? 
(iii) Does a mindfulness training app intervention have an effect on levels of psychological 
distress for people experiencing FS? (iv) Does a mindfulness training app intervention lead to 
a reduction in experiential avoidance and increase in mindfulness in people experiencing FS? 
(v) How do people with FS experience a mindfulness training app intervention? 
 
2. Method  
2.1 Design 
This study used a SCED methodology. The key advantage of this design is its ability to detect 
change on an individual level [40]. Through repeated measurement of target variables across 
distinct conditions, SCED allows participants to act as their own control rather than 
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comparing them to a group. Therefore, comparison is a central feature of this design in that it 
involves a systematic comparison of two or more experimental phases. This approach is 
particularly useful when assessing the impact of novel treatments with specific groups of 
interest [41]. Additionally, compared with larger scale group studies using pre and post 
measures only, SCED studies have the ability to give more information about the process of 
change [42].  
 
Specifically, an AB multiple baseline design [43] was used in this study. This consisted of a 
baseline “A” phase and an intervention “B” phase. In SCED studies the baseline phase is an 
integral component which allows for experimental control. The baseline consists of a period 
where data are collected before the intervention is introduced and subsequently allows for a 
comparison between the intervention phase and the baseline for each participant. An 
underlying assumption in SCED research is that changes in the target variable that occur 
upon the introduction of an intervention and do not occur at other times are likely to be 
caused by that intervention [40]. Participants were recruited on a rolling basis which ensured 
that the phases were staggered for each participant which introduced randomization to the 
design, thus increasing the internal validity [44]. This specific SCED design was chosen as it 
allowed for numerous participants rather than just one, and its suitability to measure change 
over time compared to an introduction/withdrawal design such as ABAB. Participants 
completed a baseline phase (A). Following this, participants completed the intervention phase 
(B) where they engaged with the intervention. 
 
    2-11 
2.2 Participants 
Participants were recruited online with the support of a third sector organisation that provides 
advocacy, support and research into functional neurological disorders. Those who met the 
following inclusion criteria were invited to take part in the study: (1) had a current diagnosis 
of FS (or NEAD/PNES), (2) were over 18 years of age and able to provide consent to 
participate, (3) did not have a diagnosis of epilepsy, (4) were not currently experiencing 
addiction or psychosis, (5) did not have a current regular mindfulness practice, and (6) were 
not currently engaged in another psychological intervention. 
 
The exclusion criteria around addiction and psychosis were chosen in order to maximise the 
safety of participants. In rare cases, mindfulness practice has resulted in difficulties for 
people who have experience of psychosis [45] and caution has been advised around its use 
with people experiencing addiction [46]. 
 
2.3 Intervention 
The mindfulness training intervention used was the Smiling Mind smartphone app [47]. The 
app was developed by psychologists to provide mindfulness training in an accessible format. 
This particular app was chosen due to its quality rating [48] and its mirroring of meditations 
used in mindfulness programmes with an established evidence base such as mindfulness-
based stress reduction [49]. Additionally, the app has been developing its own evidence base. 
For example, it has led to improvements in depressive symptoms, college adjustment and 
resilience in an RCT involving 208 undergraduate students [50] and a further study 
demonstrated a reduction in the concentration of salivary cortisol in a sample of athletes 
using the app during a competition [51]. 
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2.4 Measures 
All data in the study were collected via the Qualtrics online data collection platform. 
Participants were sent a link each day of their active participation in the study to complete the 
relevant measures. See Table 2 for a summary of the measures used and their psychometric 
properties. 
 
The study collected the following data on a daily basis: 
Seizure frequency was a self-reported measure of the number of FS experienced in the 
previous 24 hours. For the purpose of this measure a non-epileptic seizure was self-defined 
by each participant. 
 
Quality of life (QoL) was measured using the five-item work and social adjustment scale 
(WSAS) [52]. This measures functional impairment caused by FS in the domains of work, 
home management, social leisure activities, private leisure activities, family and 
relationships. The measure has been validated in a variety of healthcare populations [53] and 
has been used in an online study of FS [26]. 
 
Further measures used in this study were collected at baseline, weekly during the active phase 
of the intervention and at four-week follow-up: 
The 7-item acceptance and action questionnaire (AAQ-II) [25] was used to measure the 
process of experiential avoidance. This measure has previously been used online in FS 
research [26]. 
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The 15-item five factor mindfulness questionnaire (FFMQ-15) [54] which measures the  
mindfulness traits of  observing, describing, acting with awareness, being non-judgemental 
and non-reactive. This was used to measure the process of mindfulness trait development. 
 
The CORE-10 (10 items) [53] is a measure of broad psychological distress and was used to 
monitor participants’ levels of distress throughout the study.  
 
Participants were also asked to report the number of sessions of meditation that they 
completed each week using the app. 
 
Finally, a brief change interview based on Elliot [55, 56] was administered by phone at one-
month follow-up to assess the participants’ experiences of the intervention, to develop an 
understanding of any qualitative benefits or difficulties experienced.  See Table 1 for the 






Table 1 - Change Interview Schedule 
 Theme Question 
1. General 
Experience 
What has using this intervention been like for you? 
2. Changes What changes, if any, have you noticed in yourself since you began using 
this intervention? 




How likely do you think that these changes would have been without the 
intervention? 
4. Expectedness Did you expect any of those changes? 
5. Importance On a scale of 1 to 5, how important would you rate these changes? 
6. Attribution In general, what do you attribute these various changes to? 
7. Resources What personal strengths or aspects of your current life situation have 
helped you to use this intervention to deal with your problems? 
8. Limitations What things about you or your life situation have made it harder for you 
to use teaching from this intervention to deal with your problems related 
to NEAD or general wellbeing? 
9. Helpful aspects What have been the most helpful things about the intervention? 
10. Problematic 
Aspects 
What kinds of things about the intervention have been hindering, 
unhelpful, negative or disappointing for you? Was there anything that 
was difficult or missing? 
11. Research 
Aspects 
What has been like for you to be involved in this research? 
12. Open Is there anything else that you’d like to add? 
 
2.5 Ethics 
Ethical approval was received from Lancaster University Faculty of Health and Medicine 
Research Ethics Committee. 
 
Due to the nature of this study involving a psychological intervention the safety of 
participants was a central concern. While mindfulness practice is a low risk activity, in very 
rare instances it may lead to the experience of distress. The study took a number of steps to 
mediate this. Firstly, the risk was reduced through the use of a publicly available smartphone 
app which has been judged to be safe and using exclusion criteria to ensure those at greater 
risk of harm did not take part. Throughout the active intervention phase of the study, 
participants were offered a weekly phone or video call with the researcher. This sought to 
identify whether any participants were experiencing any harm. The researcher engaged in 
regular supervision during the intervention phase of the study and the field supervisor who is 
an expert in the field of FS provided oversight.  
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As participants were required to spend a significant amount of time completing tasks related 
to the study, they were offered a voucher for a maximum of £41.05 to compensate them for 
their time. Additionally, the payment was provided in line with NHS Health Research 
Authority guidance [57]. In adhering to this guidance, the payment was not excessive and 
was available to all participants who completed any part of the study on a pro-rata basis.  
 
2.6 Procedure 
Recruitment was conducted online, via a third sector organisation who shared details of it 
across their social media platforms.  
 
Participants responded to the advertisement and all those interested were provided with a 
participant information sheet, had a further discussion with the lead researcher about the 
study and completed a screening and demographic questionnaire. Eligible participants who 
wished to take part then completed an online consent form. 
 
Firstly, participants submitted baseline data, measuring seizure frequency and QoL on a daily 
basis. Where the baseline was stable, defined in line with guidance from Kratochwill et. al. 
[43] as level, not changing, or deteriorating, the intervention was started after seven days. 
Where data were trending in a therapeutic, improving direction the baseline phase was 
extended by three days at a time and reassessed. The baseline was not extended by more than 
six days for any participant due to the additional demand that this placed on participants.  
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After completing baseline measures, participants engaged in a mindfulness training 
intervention using the Smiling Mind app [47] over the course of seven weeks. Participants 
were asked to complete the “introduction to mindfulness” and “mindfulness foundations” 
programmes using the app. These two programmes provided teaching and guided meditation 
sessions that varied in length from one to 40 minutes with an average of nine minutes. A set 
of six to seven exercises from the app were recommended to each participant each week and 
they worked through them at their own pace. While engaging in the intervention, participants 
received a link daily to submit measures of seizure frequency and WSAS and weekly to 
complete the remainder of the measures. Throughout the intervention, the researcher offered 
a weekly phone-call to monitor participants’ safety and reflect on their experience of the 
intervention. 
 
Four weeks after finishing the intervention, participants completed a follow-up set of daily 
and weekly measures along with a change interview with the researcher over the telephone 
which was recorded and transcribed verbatim. 
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Table 2 - Psychometric Properties and Characteristics of Measures 
 
 Construct No. of 
items 




Scale Range and Direction 
Daily measures       
Seizure frequency Number of 
seizures daily 
 
1 “How many seizures have you experienced over the past 
24 hours?” 







5 “Because of my seizures my social leisure activities (with 
other people e.g. parties, bars, clubs, outings, visits, 
dating, home entertaining) are impaired” 
.87[26] .73[52] 0-40 
Higher score = greater impairment 
Weekly 
measures 
      
CORE-10[53] Psychological 
distress 
10 “I have felt despairing or hopeless” .9[53] .83[58] 0-40 






7 “I worry about not being able to control my worries and 
feelings” 
.84[25]  .81[25] 7-49 
Lower scores = greater psychological 
flexibility, less experiential avoidance 
FFMQ-15[59] Observe 3 “I pay attention to sensations, such as the wind in my hair 
or sun on my face” 
.64[54] - 3-15 
 Describe 3 “I’m good at finding words to describe my feelings” .8  3-15 
 Acting with 
awareness 
3 “I find myself doing things without paying attention” .68  3-15 
 Non-judging 3 “I tell myself I shouldn’t be feeling the way I’m feeling” .76  3-15 
 Non-reactivity 3 “When I have distressing thoughts or images I just notice 
them and let them go” 
.66  3-15 
Higher scores = greater levels of 
mindfulness 
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2.7 Analysis 
All data was transferred by the researcher from Qualtrics to a Microsoft Excel spreadsheet 
where further analysis was undertaken and graphs were produced. 
 
Baseline data were assessed using SPSS, a line of best fit was drawn to assess the direction of 
the trend in the data. Once this was either stable, trending in a non-therapeutic direction or 
after the maximum baseline extension the intervention phase started. 
 
A visual analysis [60] was conducted of the daily measures. Firstly, all quantitative data 
collected from each participant was plotted on a line graph. This was then assessed for trend, 
level and stability. Trend lines were drawn for daily measures using the “split-middle” 
method of trend estimation [60].  Percentage exceeding the median (PEM) [61] statistics 
were used to assess the effect size of the intervention. This method involves calculating the 
median for the baseline and assessing the percentage of data points that exceed this in a 
therapeutic direction. PEM was used on the measures for which sufficient data points were 
available – seizure frequency and WSAS. 
 
Change was assessed between pre-intervention and post-intervention on the WSAS, CORE-
10, AAQ-II and FFMQ-15. In order to assess whether changes observed were reliable and 
clinically significant, analysis of reliable change index (RCI) was conducted using guidance 
provided by Jacobson and Truax [62]. Where reliable change was found, clinically significant 
change CSC was assessed using the criteria outlined in Jacobson and Truax [62]. Under 
criterion c from this method, CSC is met when a participant’s post-intervention score is 
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closer to the mean score of the non-clinical group than that of the clinical group. As this is 
described as the least arbitrary of the three criteria [62] available and means and standard 
deviations were available from appropriate samples (see Table 3), criterion c was applied in 
this study. 
 
Table 3 - Papers used for CSC calculations 





    
AAQ-II Bond et. al. [25] Community 
(568) 
18.53 7.52 
CORE-10 Bewick et. al. [63] Students (1,129) 8.47 6.41 
WSAS Dawel et. al. [64] Community (1,296) 20.5 9.3 
FFMQ - O Ortet et. al. [65] Community (55) 9.91 2.23 
FFMQ - D  Community (55) 10.31 2.62 
FFMQ - A  Community (55) 8.82 1.98 
FFMQ – NJ  Community (55) 11.02 2.78 
FFMQ - NR  Community (55) 8.89 2.0 
Clinical 
Samples 
    
AAQ-II Baslet et. al. [66] FS (31) 28.98 12.15 
CORE-10 Goldstein et. al. [22] FS (368) 18.2 6.5 
WSAS Mayor et. al. [67] FS (36) 22.4 11.3 
FFMQ - O Gu et. al. [54] Depression (238) 
 
8.98 2.73 
FFMQ - D   9.84 2.74 
FFMQ - A   9.1 2.25 
FFMQ – NJ   9.43 2.67 
FFMQ - NR   8.58 2.3 
AAQ-II = Acceptance and action questionnaire; WSAS = Work and Social Adjustment Scale; FFMQ 
= Five factor mindfulness questionnaire – 15 item; O = Observing; D = Describing; A = Awareness; 
NJ = Non-judging; NR = Non-reactivity. SD = standard deviation 
 
Framework analysis [68] was used to analyse participants’ responses to the change interview. 
It was chosen as it is often used to answer pragmatic questions and allows themes to be 
influenced a priori from research questions while also allowing for emergent themes from the 
data. Here, the analysis was guided by the questions in the change interview and the findings 
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were used to support or challenge those of the quantitative methods and to answer the final 
research question. This method represented a descriptive rather than an interpretative 
analysis. It involved coding the transcribed interview from each participant, developing a 
chart which represented the key themes covered by the change interview questions and 
adding each response to the chart alongside the most appropriate theme. Any outstanding 
data that did not fit with the chart could be developed into additional themes as appropriate. 
3. Results 
3.1 Sample demographics and adherence 
Nine potential participants expressed an interest. However, three of these did not proceed due 
to additional life stresses (1) and not meeting the inclusion criteria (2). Six participants were 
recruited to the study. Over the course of the study, one participant dropped out after 
completing three weeks of the intervention and did not have any further contact with the 
researcher. Another participant was diagnosed with epilepsy during the study which meant 
that they no longer met the inclusion criteria, therefore this participant’s data were not 
analysed. Full datasets from four participants who completed the study are reported here 
along with a partial dataset from the fifth participant who left the study early. Table 4 shows 
the demographics of the sample. There were four females and one male, ages ranged from 
22-41 (mean age = 35.2). Three participants were engaged in university-level education, one 
of whom had paused their education due to difficulties associated with FS. The remaining 
two participants were not in employment at the time of the study, one of whom had ceased 
working due to difficulties with FS. Four participants described experiencing mental health 
difficulties alongside their FS. 
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In terms of adherence, P1, P2 and P4 showed high levels with each reporting that they 
completed in excess of five sessions of practice each week during the intervention phase. 
Mean reports of sessions completed each week were; 5.1 for P1, 7.2 for P2, 1.8 for P3 and 
8.4 for P4. P5 reported completing a total of four sessions. 
 
Table 4 - Demographics of sample 







































4 44 Female Mood 
difficulty 
1 year September 
2019 
No Not currently 
working due 
to FS related 
disability 
Full 











M/H; mental health diagnosis, PTSD; Post-traumatic stress disorder, FS symptoms; duration of FS 
symptoms at the time of the study 
 
3.2 Visual Analysis 
Graphs showing the quantitative measures for all participants are displayed in Figure 1. 
Formal visual analysis techniques [60] were used to analyse the measures collected daily i.e. 
seizure frequency and WSAS. A demonstration of all analysis methods used can be found in 
appendix 2 – A. 
 
Assessment of the baseline measure of seizure frequency showed that it was stable or 
increasing for all participants with the exception of participant 2 whose baseline was 
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extended for 6 days in an effort to reach stability. However, as this was not reached by day 13 
the intervention was started at this point due to the ethical implications of increasing the 
burden on the participant by delaying the start further. 
 
Visual analysis of P1’s seizure frequency showed a flat but unstable trend in the baseline 
phase. For P2 the trend at baseline was improving but unstable. The data for both P1 and P2 
was flat and stable at 0 in the intervention phase. The trend for P3’s seizure frequency data 
was flat in both the baseline and intervention stages though it was unstable in both conditions 
and there was a deterioration in the level with an increase of +2 in the median. In P4’s case 
the trend changed from flat and stable at baseline to improving in the intervention phase. 
However, the data for P4’s seizure frequency was variable with a stability rating of 19.15% 
and showed a deterioration in level with an increase in the median score of +5. P5’s data 
showed a change from improving in the baseline to deteriorating in the intervention phase, 
the data for both of which were variable. 
 
WSAS trends for P1 and P2 moved in a negative direction indicating a reduction in difficulty 
during the intervention. For P1 this changed from a deteriorating trend in the baseline while 
for P2 the improvement was from a less steeply improving trend in the baseline phase. In 
P3’s case, the trend moved from an increasing (thus deteriorating) trend in the baseline phase 
to a reducing, improving trend in the intervention. However, there was a median level change 
of +3.5 meaning that despite the decreasing trend, P3’s WSAS scores in the intervention 
phase were higher than those in the baseline. P4’s WSAS score changed from a reducing, 
improving trend in the baseline phase to an increasing, deteriorating trend in the intervention 
phase as did that of P5. 
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Alongside the formal visual analysis, representation of the data in graph format shows that as 
P1 and P2’s scores on the outcome measures of WSAS and CORE-10 decreased, their scores 
on the AAQ-II process measure similarly reduced. Additionally, a marginal increase in the 
process measures of mindfulness was observed for both participants. Similar patterns were 
not observed for the remaining participants. 
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Figure 1 - Visual Presentation of data including trend lines for WSAS and seizure frequency for each participant 
 
Note: WSAS = Work and social adjustment scale; FFMQ-15= Five factor mindfulness scale 15 item. Graphs are presented in the same scale to aid 
comparison. As a result, three data points on the daily seizure measure for P4 are missing. They are day 26 = 79, day 34 = 91, day 52 = 97. Black lines on 
WSAS and daily seizure frequency are trend lines calculated using the “split-middle” method
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Note: WSAS = Work and social adjustment scale; FFMQ-15= Five factor mindfulness scale 15 item. Graphs are presented in the same scale to aid 
comparison. As a result, three data points on the daily seizure measure for P4 are missing. They are day 26 = 79, day 34 = 91, day 52 = 97. Black lines on 
WSAS and daily seizure frequency are trend lines calculated using the “split-middle” method.
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Note: WSAS = Work and social adjustment scale; FFMQ-15= Five factor mindfulness scale 15 item. Graphs are presented in the same scale to aid 
comparison. As a result, three data points on the daily seizure measure for P4 are missing. They are day 26 = 79, day 34 = 91, day 52 = 97. Black lines on 
WSAS and daily seizure frequency are trend lines calculated using the “split-middle” method.
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3.2.1 Effect size - Percentage Exceeding the Median 
Ma’s PEM [61] method was used to calculate effect size. This recommends the application of 
“highly effective” for scores over 90%, “moderate” between 70% and 90%, “mild effect” 
between 50% and 70% and considers scores below 50% to be “ineffective.” 
 
For seizure frequency this calculation found a moderate effect size of 79% for P2 and a mild 
effect size of 50% for P5. An effect size of zero was found for the remaining participants as 
the median seizure frequency score for each was 0 in the baseline phase. 
 
Effect sizes on the QoL measure were in the moderate range for P1 and highly effective 
range for P2 with PEM scores of 86% and 94% respectively. The scores for the remaining 
participants fell in to the “ineffective” range with effect sizes of 22% for P3, 21% for P4 and 
12.5% for P5. 
 
3.3 Quantitative Results 
3.3.1 Reliable and clinically significant change 
See Table 5 for a summary of quantitative results for each participant showing RCI and CSC.  
 
On the WSAS, scores from P1 and P2 showed reliable and clinically significant improvement 
at both post-intervention and follow up. Again, the scores from the remaining participants did 
not meet either RCI or CSC. 
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On the CORE-10 measure of distress, P1 and P2 showed a reliable improvement post-
intervention. This was clinically significant for P2. This change remained reliable at follow 
up and scores for both P1 and P2 were clinically significant at this time. The scores for P3, 
P4 and P5 did not meet RCI or CSC on this measure.  
 
On the AAQ-II process measure, P1 and P2 showed RCI in a therapeutic direction between 
baseline and post-intervention. This was maintained at follow-up. For P2 the change met 
CSC post-intervention and at follow up. However, for P1 this reached CSC only at follow up. 
No other participants met RCI or CSC criteria on this measure. 
 
The FFMQ-15 subscale for observing measured reliable and CSC for three participants (P1, 
P2 & P3) post-intervention. At follow-up this was maintained by one of these participants 
(P2). A reliable deterioration on this measure was observed for P4. 
 
For the describe subscale of the FFMQ-15, P1 P2 and P4 showed RCI post-intervention. This 
met CSC for P2 and for P4. At follow-up, RCI was maintained for P1 and P2 with both 
showing CSC. However, the score for P4 was no longer reliably improved at follow up. The 
scores for the remaining participants did not show RCI. 
 
The FFMQ-15 acting with awareness subscale found reliable improvements post-intervention 
for P2 and P4, both of which met the criteria for clinical significance. At follow up, P4 no 
longer met either criteria while RCI and CSC for P2 was maintained. P1 also showed RCI 
and CSC at this time. No further RCI or CSC were observed. 
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On the non-judging subscale of the FFMQ-15, P2 and P4 showed reliable, clinically 
significant improvements post-intervention. At follow up P4 no longer met either criteria 
while RCI and CSC for P2 was maintained. P1 showed reliable and clinically significant 
change at this time. P3 showed a reliable deterioration post-intervention which was not 
sustained at follow-up. 
 
On the non-reactivity subscale of the FFMQ-15, only P2 showed reliable and clinically 
significant improvement post-intervention. At follow-up, RCI and CSC was observed for 
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Participant Time AAQ-II WSAS CORE-10 FFMQ - O FFMQ – D FFMQ – A FFMQ - NJ FFMQ - NR 
1 Pre 42 27 30 9 4 7 10 6 
 Post 24R+ 10R+, c 17R+ 15R+, c 9R+ 9 10 9 
 Follow-up 15R+, c 9R+, c 13R+, c 13 11R+, c 11R+, c 15 R+, c 11R+, c 
2 Pre 34 19 19 7 7 5 6 8 
 Post 18R+, c 6R+, c 12R+, c 13R+,  c 11R+, c 11R+, c 11 R+, c 12 R+, c 
 Follow-up 17R+, c 6R+, c 10R+, c 13R+,  c 13R+, c 12R+, c 15R+, c 12 R+, c 
3 Pre 16 11 13 5 8 11 10 8 
 Post 18 20 17 12R+, c 8 9 5R- 10 
 Follow-up 22 12 17 9 5 12 9 9 
4 Pre 14 27 10 11 6 9 11 13 
 Post 13 27 12 6R- 14R+, c 13R+, c 15 R+, c 14 
 Follow-up 10 - 11 6R- 8 8 14 15 
5 Pre 39 39 26 9 6 8 9 8 
 Post 48 40 27 5 5 6 7 6 
 Follow-up - - - - - - - - 
Lower scores indicate improvements on the AAQ, WSAS and CORE-10. Higher scores indicate higher levels of mindfulness on the FFMQ. FFMQ-O: 
observing, FFMQ-D: describing, FFMQ-A: Awareness, FFMQ-NJ: Non-judgement, FFMQ-NR: Non-reactivity. R: Indicates reliable change. R+ indicates 
an improvement, R- indicates a deterioration. - indicates that data was missing for this calculation. c: indicates that criterion C for CSC was met. Post data 
for P5 were taken from the last date that they submitted data. 
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3.4 Qualitative Data 
The four participants who completed the intervention in full also took part in a change 
interview about their experience. Using a framework analysis [68], participant responses 
were coded according to subthemes guided by the questions in the change interview. See 
Table 6 for a summary of responses. No additional themes emerged. Subsequently, these 
subthemes were grouped into broader themes of: general experience, helpful and problematic 
aspects; change; resources and limitations; and research participation.  
 
3.4.1 Theme 1 – General experience, helpful & problematic aspects  
Participants’ general experience with the app was positive. Participants spoke about how the 
app facilitated their learning of mindfulness skills in a number of ways such as supporting 
their development of a routine (P4), clarifying mindfulness concepts (P2) and P1 described 
the general experience as allowing her to feel more tuned in to how her body and mind work. 
 
Participants identified the fact that meditations were guided as a helpful aspect. Additionally, 
P2 noted the benefit of recording the frequency of her seizures while taking part in the 
research. P3 reported the benefits of contact with the researcher highlighting the importance 
of having somebody to communicate with about FS.  
 
Considering problematic aspects of the intervention, P1 and P2 reported difficulty with the 
longer sessions which were introduced in the final weeks of the intervention. Additionally, P3 
noted difficulties with the accent, he also highlighted that there are a lot of options within the 
app and that it may have been a struggle to choose an appropriate one without guidance. 
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Finally, a problematic aspect noted by P4 was that the practice did not have an effect on her 
seizures as she would have liked. 
 
3.4.2 Theme 2 - Change 
All participants reported some change as a result of using the app. P1 and P2 reported an 
effect on their seizures, highlighting that using the app resulted in “less seizures” and feeling 
less bothered by them” (P2). Additionally, both noted this reduction had led to improvements 
in their daily lives to the extent that made it possible for them to continue in their studies. P3 
didn’t note any direct change in relation to seizures or well-being but did express that he 
experienced a greater awareness “an improvement with my conscious appreciation of what's 
causing problems” (P3). P4 reported feeling more relaxed and having greater control over 
situations that could otherwise lead to a state of panic. In relation to the likelihood of change, 
P1, P2 and P4 noted that they did not believe that they would have experienced the changes 
described without having used the app. Additionally, all participants reported that these 
changes were unexpected and important.  
 
Participants attributed changes to a range of processes. P1 and P2 placed emphasis on 
slowing down “Some days I just need to have a day to myself to just relax. And it’s been very 
useful actually” (P1), “it’s kind of letting myself see things can be calm, things don’t have to 
go 100 miles an hour all the time and that makes all the difference” (P2). Similarly, P3 
highlighted the importance of “timing, patience and temperance” (P3). Whereas P4 noted 
improvements in her sleeping pattern that led to further benefits in terms of managing stress. 
 
    2-35 
3.4.3 Theme 3 – Resources and Limitations 
Considering the personal resources that supported their engagement with the app, participants 
provided a variety of responses. P1 highlighted the benefits of a supportive partner and 
family, whereas P2 identified a level of personal determination that supported her to 
complete the programme. Somewhat similarly, P4 highlighted a level of determination 
developed through her belief that the app could be beneficial. 
 
Turning to limitations originating in participants’ lives that prevented them from engaging 
with the intervention, P2 highlighted difficulty continuing her practice while staying with 
friends as she did not feel comfortable to practise mediation in that environment. P3 
highlighted that they have a range of other supports in place and noted that engaging fully 
with the app may displace some of these other supports. P4 reported distraction while trying 
to follow guided meditations as a difficulty. 
 
3.4.4 Theme 4 – Research participation 
Considering the research aspect of taking part in this study, participants highlighted the 
intensity of completing measures every day (P1). P2 and P4 highlighted the benefits of 
contributing to the knowledge base around FS. Finally, P3 noted the utility of collecting 
information as part of the study as this supported him to build an understanding of his own 
experience and he could share this with healthcare professionals. 
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Table 6 - Sample responses according to subtheme for each participant 
 




A tool that helps me like, well. 
It helps me engage in myself 
more, more in tune with how 
my body works and how my 
minds works. 
Yeah really good.  
 
The more that I practiced doing 
the mindfulness it just seemed 
an easier concept. 
I don't normally have these 
mindfulness apps, that style, the 
smiling mind installed, so 
having it there and keeping it 
there is a very conscious 
reminder to use it. 
 
I would say using the 
mindfulness, I now use it 
everyday. Whereas before I’d 
never used it and now I use it 
every single day as part of 
relaxation. Trying to cope with 
what I am trying to deal with on 





I’m a lot more confident and 
I’m less reserved now. And I 
think I’m a lot more calm. 
When I do have a spell of 
anxiety or something I do a 
meditation and calm myself 
down. 
 
And since doing the 
intervention I’m now able to 
start doing my teacher training 
again. Yeah so I started doing 
my teacher training again, I’m 
getting my life back really. 
More independently I’ve driven 
to one side of the country this 
month and pervious month a 
drive to the other side. 
 
I’ve gone through the whole of 
lockdown not having had one 
seizure. And I didn’t have one 
passing out which is quite weird 
really because there was a lot of 
stress in the world. 
Yeah I suppose less seizures. 
And also feeling less bothered 
by them. I’ve sort of maybe 
been having like one a week 
tops. And they hardly last and 
I’m kind of just not phased by 
them. 
 
And it’s just not as scary and I 
kind of can tell when I’m going 
to have one now I’ve started to 
notice I can kind of say “I’ve 
had a really stressful day today, 
I need to take some time to 
unwind” because otherwise I 
know normally if I’ve had a 
really busy day I might have a 
seizure. 
I would say that there is an 
improvement with my 
conscious appreciation of what's 
causing problems, in 
mindfulness, and I know that 




Yeah I’m more relaxed. I’m not 
overwhelmed with everything. I 
take it as it comes and then deal 
with it slowly, whatever I have 
to deal with first. I don’t seem 
to panic as much. 
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Subtheme P1 P2 P3 P4 
Likelihood without intervention 
2 
Not very likely at all (laughs). 
Yeah I kind of hit a rock 
basically and I didn’t know 
what to do. 
So personally I think, I think I’d 
still be in the same boat if not 
worse if I hadn’t of done it. 
 
I did not expect that change. Not very likely. In the sense of I 
think the panics the worries, 
trying to manage everything 
would have worsened. I think 
I’d probably have had to seek 
medical advice because you 
know, they wouldn’t be able to 
help. But trying to deal with it 




I didn’t expect any of them at 
all to be honest.  I was like it’s 
gonna be a thing that I have to 
do every single day and all that 
kind of stuff and no it’s changed 
quite a lot and everyone’s said I 
hold myself a lot better now I’m 
confident, I’m becoming more 
like my old self from before my 
NEAD and FND. 
 
Honestly, I don’t know for sure 
but I feel like it’s massively 
helped. 
I did not expect that change. Not really. Because I’ve looked 
at mindfulness before but in 
books. I’ve got relatives, my 
daughter and my sister have 
both given me books to read and 
the reading part of it, not that I 
didn’t understand it, I couldn’t 




Yeah definitely a five. Cos in 
order for me to start my 
teaching degree I needed to be a 
bit more confident in myself. 
Needed to be more relaxed, 
needed to be able to deal with 
stress because obviously it’s a 
very stressful job. And it’s 
given me the tools in order to so 
and you know I’m going in to a 
classroom next week and I’m so 
excited instead. 
 
Five out of five, massively 
important. 
When I speak to [the 
Neurologist], I was mentioning 
pain and how that was affecting 
me. That was important at the 
time, so it brought about 
significance to the conversation 
with the neurologist, that was 
important. So that was a change 
that was valued, I think. 
I would say four, four to five. 
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Subtheme P1 P2 P3 P4 
Attribution 
2 
I think with me being more in 
tune with myself. I know when 
things are too much and when 
things are just about right and 
when things are perfect. I know 
what to do when things are 
getting bad and what to do if 
they’re good. I can’t put too 
much stress on myself, I can’t. 
Some days I just need to have a 
day to myself to just relax. And 
it’s been very useful actually. 
 
Definitely doing all of the 
mindfulness and I think time 
aswell. I think there was an 
element of getting used to 
things, getting my head around 
things you know but doing the 
mindfulness training its just 
kind of made me pause. 
 
The whole situation has just 
forced me to pause, kind of look 
at myself and go “I’m going 100 
miles an hour here and that’s 
just not manageable, how can I 
slow down and mindfulness has 
been one of those things that’s 
given me that space and I feel 
like when I do it, it’s kind of 
letting myself see things can be 
calm, things don’t have to go 
100 miles an hour all the time 
and that makes all the 
difference. 
 
Timing, patience and 
temperance. 
Mainly my sleep. Controlling 
my calmness before I go to 
sleep is the biggest change 
because then I wake up not 
worrying or thinking about what 
I’ve got to do with the next day. 
And that’s the biggest cos 
otherwise if I stress or worry 
before I go to bed I obviously 
don’t get enough sleep so then I 
am more stressed or more 
worries thinking about it, can’t 
relax, trying to deal with it and 
it just gets worse. The before 
going to bed is the biggest 
change for me. 
Resources 
3 
Yeah I mean it’s helped a lot in 
my relationships like with my 
partner and with my family. 
Because they got into the habit 
... And we’ve got a lot better of 
a relationship now and we’ve 
got a lot more communication. 
Then my partner was constantly 
reminding me everyday “have 
you done your mindfulness?” 
 
I’m definitely the kind of person 
who if someone gives me like a 
challenge or a goal that I have 
to do it so in that sense having 
this OK like you have to do this 
every day for seven weeks. I 
was like “yep, challenge 
accepted” I don’t like to do 
things by halves so I really 
wanted to give it my full. 
I've tried to integrate what I'm 
using into other areas. So I'm 
trying to what you might say, 
marry or match the common 
fascinations of trending use in 
assessing states of mind and 
behaviour from online apps 
which are obviously very 
convenient and widely 
available. 
I think for me it was knowing 
that it may make a difference 
with my whole life. The fact 
that I’m trying to deal with FND 
and the fact that it might be able 
to help with my everyday 
issues. That was the 
determination for me. 
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We were staying at a friend’s 
house for one of the nights for a 
couple of the nights, I didn’t 
feel like I could do it there. 
So the one thing that would 
interfere with this, it would be 
well, should I displace anything 
that is already there? 
 
This has been, I guess, another 
reason why I would not actively 
follow the strict you know, daily 
or twice a day routine, 'cause 
I'm doing other things. 
 
Yes, I am easily distracted. 
Very easily distracted. So trying 
to remind myself, that’s why at 
bedtime was the easiest time to 
do it. Whereas trying to get 
myself to focus on it through the 
day it was so much harder. So 




I think, the one I use the 
majority of the time is “mindful 
eating” so like instead of just 
eating a piece of fruit, I’ll take 
my time eating a piece of fruit 
and notice where things are 
going and it’s digestive track 
and where can I feel it in my 
tummy and the feelings that I 
feel when I eat such a thing. In 
fact at the weekend I decided 
I’m going to have a bar of 
chocolate and instead of eating 
it all at once you know, I 
savoured it, I basically looked at 
it explored it, ate it, explored it 
in my mouth, and then I did that 
and it feels really good to do 
that and be more mindful 
without even people knowing. 
 
Definitely helped that it was 
guided. 
 
Recording my seizures 
everyday, … so I think that 
because I was having to 
remember how many seizures 
have I had in the last 24 hours, 
writing it down and then it 
helped me to remember so then 
I could actually see like “oh, I 
haven’t had a seizure in a week” 
and actually seeing that was like 
really motivating aswell and 
made me feel like positive that 
things were getting better cos I 
could actually see the 
improvement. 
Having someone to 
communicate, record and create 
a, a segment of my life, I think 
is very important. As I said in 
my feedback in survey there's 
been zero help and support, and 
my view is that there is 
essentially something very close 
to that value in the NHS. 
Yeah the most helpful part of it 
is knowing how to bring my 
distraction back to what I’m 
focusing on. That’s the best 
thing for me. Before when it 
was talking about trying to stop 
your mind from wandering and 
then it talks to you about 
exploring what your mind is 
wandering to, what your mind is 
wandering at and you know 
what is it thinking of how did it 
get to that part. And then 
bringing it back. 
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Subtheme P1 P2 P3 P4 
Problematic aspects 
1 
No really no, the only thing that 
can spring to mind is the longer 
sessions on Smiling mind. Like, 
sometimes I don’t have the time 
to do the longer sessions. 
Though it was just the case of 
“no I’ve got to do this” and it 
could be the case if I have to 
rush to do It and I want to take 
my own time and, but that was 
the only thing really. 
 
I think like the longer ones were 
quite hard. Especially because 
even though its half an hour or 
45 minutes out of your day, I 
still felt like that is a lot of time. 
The five to ten-minute ones I 
could do and it felt realistic but 
there was just something about 
doing the half an hour or 45 
minute ones that I just really 
struggled with. 
 
I couldn't get on with the 
accent…  I would have 
preferred an English female, but 
that's a matter of preference. 
 
I think that that's about the only 
thing that I could complain 
about. 
 
There was a very diverse list of 
options and available categories 
of approach, maybe technique, 
and you provided some 
guidance on that, but if I was 
not given that guidance, I think 
I would be very lost  
 
I was hoping it would have an 
impact on the seizures. But 




I’m not going to lie it was very 
intensive with the 
questionnaires and stuff. But 
obviously it has benefitted me a 
lot. And I’ve gone from, I’ve 
gone through the whole of 
lockdown not having had one 
seizure. And I didn’t have one 
passing out which is quite weird 
really because there was a lot of 
stress in the world. 
 
Yeah really interesting actually. 
Especially from cos I’m a 
student nurse and we look at 
obviously research papers and 
stuff so it’s been interesting to 
kind of see how it all comes 
together in the background. 
From a you know everyday 
person perspective. I like OK 
this is either going to be really 
helpful to me or, hopefully its 
going to help loads of people 
and I felt like contributing to 
something. 
 
To collect this information as 
little bite-size surveys, which is 
very useful to look and reflect 
on. 
It’s been really important for me 
to be a part of it like  because 
of, because I have FND and 
there isn’t really much research 
regarding it, it’s important for 
me to make a difference or 
know that I might be making 
someone, help towards knowing 
how it works because obviously 
it effects everybody so 
differently and a small 
contribution that I can make to 
that, that’s really important to 
me. 




4.1 Research questions 
This project set out to address five research questions, these will now be considered in turn.  
 
4.1.1 (i) What effects does a mindfulness training app intervention have on the quality of life 
of people experiencing FS? 
Results from this study showed that for two participants (P1 and P2), there was an 
improvement in quality of life upon engaging with the mindfulness intervention used in this 
study as measured by the WSAS. The change was confirmed by visual analysis, RCI and 
CSC. Furthermore, it was maintained at 4-week follow up. Qualitative reports from both 
participants supported this finding. 
 
Conversely, this effect was not detected in the quantitative data for the remaining participants 
in the study. However, P4 qualitatively reported improvements in her quality of life such as a 
greater ability to manage stressful situations and improved sleep. 
 
As a result, this study was not able to satisfy the criterion proposed by Kratochwill et. al. 
[43], that a minimum of three demonstrations of effect should be observed in the visual 
analysis in order to confirm an effect in SCED designs. It is likely that the small sample size 
prevented this criterion from being met in full. 
4.1.2 (ii) Does a mindfulness training app intervention reduce seizure frequency in people 
experiencing FS? 
The quantitative measures in this study did not detect a reliable change in seizure frequency 
for any participant. While the visual analysis identified an improving trend in seizure 
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frequency during the intervention phase for P3 and P4, this was at a higher level than was 
recorded in the baseline phase for each of these participants. Additionally, P1 and P2 reported 
qualitatively that they were experiencing fewer seizures, however this was not captured by 
the quantitative seizure frequency measure. Reasons for this discrepancy include the floor 
effect observed on the daily seizure measure. As participants experienced seizure free days in 
the baseline phase, descriptive statistics such as the median were at zero pre-intervention and 
therefore any reduction was difficult to evidence. As the statistics used to detect an effect 
used in this study rely on this, they were unable to detect an effect in the intervention phase 
despite participants reporting feeling largely free from seizures in the change interview and 
neither reported a seizure in the final 11 days of the intervention. 
 
This contrasts with the limited alternative research on mindfulness for FS. For example, 
Baslet et. al. [36] did find a reduction in seizure frequency following an individual 
mindfulness-based psychotherapy intervention. However, this only assessed those who 
completed the intervention and had a high drop-out rate indicating that perhaps those who did 
not benefit may have left the study early and did not form part of the final analysis. 
 
Similarly, mixed results have been observed in large-scale trials of psychological treatments. 
For example, a recent large scale RCT investigating the benefits of CBT along with clinical 
care for FS [22] found benefits on measures of quality of life but no significant improvements 
in seizure frequency. While seizure frequency is the most common measure in FS research 
[69], it has not been standardised and is not statistically reliable. One proposal to address this 
has been the application of the clinical global impression scale [70]. However, this scale is 
based on the professional judgement of clinicians rather than the experience of people with 
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FS and may cause further difficulty in a population who often feel misunderstood by 
healthcare professionals [3] and would not be practicable in a design such as the present 
study. 
 
4.1.3 (iii) Does a mindfulness training app intervention have an effect on levels of 
psychological distress for people experiencing FS? 
Similar results to the quality of life measure were noted for this measure (CORE-10), with P1 
and P2 showing CSC improvements on the distress measure at both post-intervention and 
follow-up. Conversely, these changes were not seen for P3-5. Again, this shows some 
benefits for psychological distress for these participants, but it does not meet the Kratochwill 
et. al replication criteria [43]. 
 
The variety in the results obtained connects to a wider issue in this field of research, that of a 
completely heterogenous group. As noted in the introduction, theories on the aetiology of FS 
are far from conclusive and though people with FS may present on the surface with the same 
difficulty i.e. seizures, the aetiology and wider experience of each individual can vary 
dramatically. This was reflected in the differing responses to the intervention and has been 
noted in previous intervention studies with people with FS [22]. 
 
4.1.4 (iv) Does a mindfulness training app intervention lead to a reduction in experiential 
avoidance and increase in mindfulness in people experiencing FS? 
This study investigated process measures of experiential avoidance and mindfulness. Similar 
to the findings for other research questions, reliable change for the AAQ-II measure was 
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noted for P1 and P2. This was clinically significant at follow up for both participants. Similar 
changes were not observed for the remaining participants. 
 
We can see that for the two participants who showed improvement on the quality of life and 
distress measures, there were also improvements on the AAQ-II. P1 and P2 scored above the 
clinical cut-off range of over 24 suggested for the AAQ-II [23] before taking part in the 
intervention and scored below this cut-off afterwards while other participants did not score 
above this cut off at any point. This improvement for P1 and P2 in occurred alongside the 
improvements in quality of life and distress. This suggests that a reduction in experiential 
avoidance may have been a key process that played a part in the improvements experienced 
by these participants. Indeed, this was hypothesised in the literature [24] on FS, noting that 
increased awareness and turning towards experience may support people experiencing FS to 
develop greater awareness in these situations and thus identify a supportive response. 
Additionally, qualitative reports from these participants reflect some of these ideas. For 
example, a comment from P2 shows a change in managing seizures that reflects a change in 
experiential avoidance; “I’m kind of just not fazed by them. Whereas before I’d be like “oh 
my gosh I’m going to have a seizure I’m going to die.” Whereas now I’m like “that’s 
annoying, go away please.” This finding adds to the emerging evidence around the role that 
experiential avoidance may play in FS [26].Therefore, the result may be an indication that 
mindfulness or interventions focused on similar processes may be more beneficial for those 
experiencing FS who present with high levels of experiential avoidance. 
 
However, this finding is somewhat limited by the measure used in this study. Whilst the 
AAQ-II was developed to measure the construct of psychological flexibility and experiential 
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avoidance [23], and has been used in a large number of studies investigating third-wave 
interventions [71], the discriminant validity of this measure has questioned by Tyndall et. al. 
[72] suggesting that the measure is more akin to a measure of both distress and experiential 
avoidance. Nonetheless, the measure captures processes that are central to third-wave 
therapies and has been used in this study in the absence of a well-established alternative. 
 
Considering mindfulness, P1 and P2 showed reliable and CSC on a number of mindfulness 
facets measured by the FFMQ-15. Additionally, P4 displayed reliable and CSC on the 
awareness, describe and non-judging facet on the measure while showing a reliable 
deterioration on the observing facets. Furthermore, P1 experienced reliable and significant 
change on the observe facet. While the effects of the intervention appeared to vary across 
participants, RCI and CSC was observed in at least three participants on all of the facets in 
the FFMQ-15 with the exception of non-reactivity.  
 
This indicates that practising mindfulness using this app leads to improvements in 
mindfulness traits. The benefits experienced by participants in this study may therefore be 
linked to improvements in these such as increased awareness and less reactivity [33], 
meaning that they have an improved awareness of and control over their seizure scaffold as 
defined by Brown and Reuber [15]. In large scale studies, changes in each of these factors 
have been associated with improvements in well-being [73]. While in the present study, two 
participants (P1 and P2) showed improvements in mindfulness facets, QoL and distress, other 
participants (P3 and P4) who showed reliable change on some mindfulness facets did not 
display similar outcomes. Indeed, they may have experienced some benefits that were not 
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quantitatively measured in the study. Both participants spoke about benefits such as improved 
sleep (P4) and awareness (P3).  
 
4.1.5 (v) How do people with FS experience a mindfulness training app intervention? 
This question is answered by drawing on the themes generated in the qualitative analysis. 
Regarding the acceptability of the intervention, the results show that for all of these 
participants there was a degree of acceptability of support delivered in a way that embraces 
technology. Additionally, the completion rate was higher in the present study compared with 
traditional mindfulness interventions in this area [36]. Both of these factors show promise for 
the integration of technological solutions into healthcare treatment of those experiencing FS. 
Participants highlighted the guidance and structure that the app provided as a particular 
strength. Additionally, telephone support throughout the intervention was welcomed by 
participants. 
 
However, participants identified some difficulties with the app. Addressing these may be 
useful for the development of similar interventions. Particular suggestions revolved around 
the length of sessions. Participants noted that ten minutes felt about right for them. 
  
4.3 Limitations 
This study took place in the context of the covid-19 pandemic. This was a time of change, 
stress and crisis for the world as a whole. While little is known about the impact of this on 
people with FS, large scale research has shown that it has resulted in increased mental health 
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difficulties in the general population [74]. Given the global nature of this pandemic, it is 
likely to have affected some of the outcomes for participants in the course of this study. 
 
The AB design utilised in this study presented limits to internal and external validity. These 
include the number of replications, more of which would have increased the external validity. 
Additionally, while a degree of randomisation was achieved as participants started the 
baseline and intervention at different points, the study did not utilise a specific randomisation 
procedure which would have increased the internal validity of the study.  
 
A further limitation in this study has been the role of the researcher. As the lead researcher 
handled all aspects of recruitment, weekly contact and follow up interviews with participants, 
there is potential for this to result in a degree of response bias [75]. It would have been 
preferable to involve an independent researcher to conduct the change interviews. 
 
4.4 Future Work 
4.4.1 Clinical implications 
This type of intervention was acceptable to participants, as a result there may be scope to 
develop further interventions delivered in a similar manner for this population. Specifically, 
given the benefits to some participants and the lack of harm to others, along with the success 
of other supported, remotely delivered interventions for people with FS [27, 76, 77], there 
may be some justification for developing self-directed therapeutic supports such as apps or 
books based on third-wave approaches that are specifically designed for those with FS. It 
may be possible to use interventions such as these with people who are interested while on a 
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waiting list for further interventions, as part of a stepped care model, or as a model of 
intervention for people who find it difficult to attend appointments. 
 
4.4.2 Future research. 
Along with other studies of mindfulness in FS [17, 36], this study has shown that for some 
individuals experiencing FS, mindfulness practice may provide benefits to quality of life and 
psychological distress. However, given the mixed results from this and other studies, it is 
evident that this is not an intervention that will benefit all people with FS.  
 
The variability in response to the intervention in this study and others shows the need for 
greater research into the profiles of people experiencing FS and a need to match these with 
appropriate treatment. Therefore, a key recommendation for the future is further investigation 
into specifically who will benefit from what intervention. Within FS there is considerable 
variation in individuals’ presentations and aetiology [17]. Building this understanding may 
facilitate the matching of individuals with appropriate treatments. Indeed, a focus on 
processes such as experiential avoidance rather than on the diagnosis as a whole may be 
useful. Such research could be guided by theoretical constructs of FS such as the integrative 
cognitive model [15]. 
 
4.5 Conclusion 
While this study cannot claim to have identified strong evidence for the treatment of FS using 
a specific approach, it has shown that for some individuals with experience of FS that 
mindfulness-based interventions may be useful. Additionally, this study highlights the role 
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that experiential avoidance may play in some individuals with FS suggesting that 
interventions that reduce high levels of experiential avoidance may be beneficial. 
Furthermore, the study shows that an intervention delivered using smartphone technology can 



























1. Asadi-Pooya, A.A., et al., Terminology for psychogenic nonepileptic seizures: making 
the case for “functional seizures”. Epilepsy & Behavior, 2020. 104: p. 106895. 
2. FNDHope. Functional Seizure. 2021  [cited 2021 February 16th]; Available from: 
https://fndhope.org/fnd-guide/symptoms/seizures/. 
3. Rawlings, G.H. and M. Reuber, What patients say about living with psychogenic 
nonepileptic seizures: a systematic synthesis of qualitative studies. Seizure, 2016. 41: 
p. 100-111. 
4. Jennum, P., R. Ibsen, and J. Kjellberg, Welfare consequences for people diagnosed 
with nonepileptic seizures: A matched nationwide study in Denmark. Epilepsy & 
Behavior, 2019. 98: p. 59-65. 
5. Avalos, J.C., et al., Quality of life in patients with epilepsy or psychogenic 
nonepileptic seizures and the contribution of psychiatric comorbidities. Epilepsy & 
Behavior, 2020. 112: p. 107447. 
6. Benbadis, S.R. and W. Allen Hauser, An estimate of the prevalence of psychogenic 
non-epileptic seizures. Seizure, 2000. 9(4): p. 280-281. 
7. Duncan, R., S. Razvi, and S. Mulhern, Newly presenting psychogenic nonepileptic 
seizures: Incidence, population characteristics, and early outcome from a prospective 
audit of a first seizure clinic. Epilepsy & Behavior, 2011. 20(2): p. 308-311. 
8. Lesser, R.P., Psychogenic Seizures. Neurology, 1996. 46(6): p. 1499-1507. 
9. Seneviratne, U., et al., Medical health care utilization cost of patients presenting with 
psychogenic nonepileptic seizures. Epilepsia, 2019. 60(2): p. 349-357. 
10. Magee, J., et al., The economic cost of nonepileptic attack disorder in Ireland. 
Epilepsy & Behavior, 2014. 33: p. 45-48. 
2-51 
 
11. Reuber, M., et al., Diagnostic delay in psychogenic nonepileptic seizures. Neurology, 
2002. 58(3): p. 493-495. 
12. LaFrance, W.C. and S.C. Schachter, Gates and Rowan's Nonepileptic Seizures. 2018, 
Cambridge: Cambridge University Press. 
13. Breuer, J. and S. Freud, Studies on hysteria. 2009: Hachette UK. 
14. American Psychiatric Association, Diagnostic and statistical manual of mental 
disorders (DSM-5®). 2013: American Psychiatric Pub. 
15. Brown, R.J. and M. Reuber, Towards an integrative theory of psychogenic non-
epileptic seizures (PNES). Clinical psychology review, 2016. 47: p. 55-70. 
16. Goldstein, L.H., et al., Characteristics of 698 patients with dissociative seizures: a 
UK multicenter study. Epilepsia, 2019. 60(11): p. 2182-2193. 
17. Baslet, G., et al., Psychogenic Non-epileptic Seizures: An Updated Primer. 
Psychosomatics, 2016. 57(1): p. 1-17. 
18. Carlson, P. and K.N. Perry, Psychological interventions for psychogenic non-epileptic 
seizures: a meta-analysis. Seizure, 2017. 45: p. 142-150. 
19. Martlew, J., J. Pulman, and A.G. Marson, Psychological and behavioural treatments 
for adults with non‐epileptic attack disorder. Cochrane database of systematic 
reviews, 2014(2). 
20. Goldstein, L., et al., Cognitive-behavioral therapy for psychogenic nonepileptic 
seizures: a pilot RCT. Neurology, 2010. 74(24): p. 1986-1994. 
21. LaFrance, W.C., et al., Multicenter pilot treatment trial for psychogenic nonepileptic 
seizures: a randomized clinical trial. JAMA psychiatry, 2014. 71(9): p. 997-1005. 
22. Goldstein, L., et al., Cognitive behavioural therapy for adults with dissociative 
seizures (CODES): a pragmatic, multicentre, randomised controlled trial. The Lancet 
Psychiatry, 2020. 7(6): p. 491-505. 
2-52 
 
23. Hayes, S.C. and S.G. Hofmann, The third wave of cognitive behavioral therapy and 
the rise of process‐based care. World Psychiatry, 2017. 16(3): p. 245. 
24. Cope, S.R., N. Poole, and N. Agrawal, Treating functional non-epileptic attacks–
Should we consider acceptance and commitment therapy? Epilepsy & Behavior, 
2017. 73: p. 197-203. 
25. Bond, F.W., et al., Preliminary psychometric properties of the Acceptance and Action 
Questionnaire–II: A revised measure of psychological inflexibility and experiential 
avoidance. Behavior therapy, 2011. 42(4): p. 676-688. 
26. Cullingham, T., et al., Psychological inflexibility and somatization in nonepileptic 
attack disorder. Epilepsy & Behavior, 2020. 111: p. 107155. 
27. Barrett-Naylor, R., D.M. Gresswell, and D.L. Dawson, The effectiveness and 
acceptability of a guided self-help Acceptance and Commitment Therapy (ACT) 
intervention for psychogenic nonepileptic seizures. Epilepsy & Behavior, 2018. 88: p. 
332-340. 
28. Khoury, B., et al., Mindfulness-based therapy: a comprehensive meta-analysis. 
Clinical psychology review, 2013. 33(6): p. 763-771. 
29. Veehof, M.M., et al., Acceptance-and mindfulness-based interventions for the 
treatment of chronic pain: a meta-analytic review. Cognitive behaviour therapy, 
2016. 45(1): p. 5-31. 
30. Zhang, J., et al., Effects of mindfulness-based therapy for patients with breast cancer: 
a systematic review and meta-analysis. Complementary therapies in medicine, 2016. 
26: p. 1-10. 
31. Wood, K., et al., Mindfulness-based interventions in epilepsy: a systematic review. 
BMC neurology, 2017. 17(1): p. 52. 
2-53 
 
32. Hölzel, B.K., et al., How does mindfulness meditation work? Proposing mechanisms 
of action from a conceptual and neural perspective. Perspectives on psychological 
science, 2011. 6(6): p. 537-559. 
33. Shapiro, S.L., et al., Mechanisms of mindfulness. Journal of clinical psychology, 2006. 
62(3): p. 373-386. 
34. Baslet, G., Psychogenic non-epileptic seizures: a model of their pathogenic 
mechanism. Seizure, 2011. 20(1): p. 1-13. 
35. Arlt Mutch, V.K., S. Evans, and K. Wyka, The role of acceptance in mood 
improvement during Mindfulness‐Based Stress Reduction. Journal of Clinical 
Psychology, 2021. 77(1): p. 7-19. 
36. Baslet, G., et al., Mindfulness-based therapy for psychogenic nonepileptic seizures. 
Epilepsy & Behavior, 2020. 103: p. 106534. 
37. Tolchin, B., B.A. Dworetzky, and G. Baslet, Long‐term adherence with psychiatric 
treatment among patients with psychogenic nonepileptic seizures. Epilepsia, 2018. 
59(1): p. e18-e22. 
38. LaFrance, W.C., Jr., et al., Treatment of psychogenic nonepileptic seizures (PNES) 
using video telehealth. Epilepsia, 2020. 
39. Howells, A., I. Ivtzan, and F.J. Eiroa-Orosa, Putting the ‘app’in happiness: a 
randomised controlled trial of a smartphone-based mindfulness intervention to 
enhance wellbeing. Journal of happiness studies, 2016. 17(1): p. 163-185. 
40. Morley, S., Single Case Methods in Clinical Psychology : A Practical Guide. 2017. 
41. Sheldon, K. and J. Davies, Single Case Methodologies, in Research in Practice for 
Forensic Professionals, K. Sheldon, J. Davies, and K. Howells, Editors. 2011, 
Routledge: London. p. 161 - 188. 
2-54 
 
42. Smith, J.D., L. Handler, and M.R. Nash, Therapeutic assessment for preadolescent 
boys with oppositional defiant disorder: A replicated single-case time-series design. 
Psychological Assessment, 2010. 22(3): p. 593. 
43. Kratochwill, T.R., et al., Single-case designs technical documentation. What works 
clearinghouse, 2010. 
44. Kratochwill, T.R. and J.R. Levin, Enhancing the scientific credibility of single-case 
intervention research: Randomization to the rescue. 2014. 
45. Dyga, K. and R. Stupak, Meditation and psychosis: trigger or cure? Archives of 
Psychiatry and Psychotherapy, 2015. 17(3). 
46. Van Gordon, W., E. Shonin, and J. Garcia-Campayo, Are there adverse effects 
associated with mindfulness? 2017, SAGE Publications Sage UK: London, England. 
47. Smiling Mind. Smiling Mind App. 2021; Available from: 
https://www.smilingmind.com.au/smiling-mind-app. 
48. Mani, M., et al., Review and evaluation of mindfulness-based iPhone apps. JMIR 
mHealth and uHealth, 2015. 3(3): p. e82. 
49. Kabat-Zinn, J., Full catastrophe living : How to cope with stress, pain and illness 
using mindfulness meditation. third edition ed. 2013, London: Piatkus. 
50. Flett, J.A., et al., Mobile mindfulness meditation: a randomised controlled trial of the 
effect of two popular apps on mental health. Mindfulness, 2019. 10(5): p. 863-876. 
51. MacDonald, L.A. and C.L. Minahan, Mindfulness training attenuates the increase in 
salivary cortisol concentration associated with competition in highly trained 
wheelchair-basketball players. Journal of sports sciences, 2018. 36(4): p. 378-383. 
52. Mundt, J.C., et al., The Work and Social Adjustment Scale: a simple measure of 




53. Barkham, M., et al., The CORE‐10: A short measure of psychological distress for 
routine use in the psychological therapies. Counselling and Psychotherapy Research, 
2013. 13(1): p. 3-13. 
54. Gu, J., et al., Examining the factor structure of the 39-item and 15-item versions of the 
Five Facet Mindfulness Questionnaire before and after mindfulness-based cognitive 
therapy for people with recurrent depression. Psychological assessment, 2016. 28(7): 
p. 791. 
55. Elliott, R. and B. Rodgers, Client Change Interview Schedule v5. 2008, University of 
Strathclyde, Glasgow. 
56. Rodgers, B. and R. Elliott, Qualitative methods in psychotherapy outcome research, 
in Psychotherapy research. 2015, Springer. p. 559-578. 
57. National Health Service Health Research Authority, HRA Guidance: Payments and 
Incentives in Research v1.0 April 2014. 2014. 
58. O'Connor, G. and R. Morris, The CORE‐10 in screening for current mental health 
problems and severe mental illness in prisoners. Criminal Behaviour and Mental 
Health, 2019. 29(1): p. 43-46. 
59. Bohlmeijer, E., et al., Psychometric properties of the five facet mindfulness 
questionnaire in depressed adults and development of a short form. Assessment, 
2011. 18(3): p. 308-320. 
60. Lane, J.D. and D.L. Gast, Visual analysis in single case experimental design studies: 
Brief review and guidelines. Neuropsychological rehabilitation, 2014. 24(3-4): p. 445-
463. 
61. Ma, H.-H., An alternative method for quantitative synthesis of single-subject 
researches: Percentage of data points exceeding the median. Behavior modification, 
2006. 30(5): p. 598-617. 
2-56 
 
62. Jacobson, N. and P. Truax, Clinical Significance: A Statistical Approach to Denning 
Meaningful Change in Psychotherapy Research. Journal of  Consulting and Clinical 
Psychology, 1991. 59: p. 12-19. 
63. Bewick, B.M., et al., Using electronic surveying to assess psychological distress 
within the UK student population: a multi-site pilot investigation. E-Journal of 
Applied Psychology, 2008. 
64. Dawel, A., et al., The effect of COVID-19 on mental health and wellbeing in a 
representative sample of Australian adults. Frontiers in psychiatry, 2020. 11: p. 1026. 
65. Ortet, G., et al., Personality and nonjudging make you happier: Contribution of the 
Five-Factor Model, mindfulness facets and a mindfulness intervention to subjective 
well-being. PloS one, 2020. 15(2): p. e0228655. 
66. Baslet, G., B. Tolchin, and B.A. Dworetzky, Altered responsiveness in psychogenic 
nonepileptic seizures and its implication to underlying psychopathology. Seizure, 
2017. 52: p. 162-168. 
67. Mayor, R., et al., Short-term outcome of psychogenic non-epileptic seizures after 
communication of the diagnosis. Epilepsy & behavior, 2012. 25(4): p. 676-681. 
68. Ritchie, J. and L. Spencer, Qualitative data analysis for applied policy research, in 
Analyzing Qualitative Data, A. Bryman and R.G. Burgess, Editors. 1994, Taylor & 
Francis: London. 
69. Pick, S., et al., Outcome measurement in functional neurological disorder: a 
systematic review and recommendations. Journal of Neurology, Neurosurgery & 
Psychiatry, 2020. 91(6): p. 638-649. 
70. Busner, J. and S.D. Targum, The clinical global impressions scale: applying a 
research tool in clinical practice. Psychiatry (Edgmont), 2007. 4(7): p. 28. 
2-57 
 
71. Coto-Lesmes, R., C. Fernández-Rodríguez, and S. González-Fernández, Acceptance 
and Commitment Therapy in group format for anxiety and depression. A systematic 
review. Journal of affective disorders, 2020. 263: p. 107-120. 
72. Tyndall, I., et al., The Acceptance and Action Questionnaire-II (AAQ-II) as a measure 
of experiential avoidance: Concerns over discriminant validity. Journal of Contextual 
Behavioral Science, 2019. 12: p. 278-284. 
73. Baer, R.A., et al., Construct validity of the five facet mindfulness questionnaire in 
meditating and nonmeditating samples. Assessment, 2008. 15(3): p. 329-342. 
74. O'Connor, R.C., et al., Mental health and well-being during the COVID-19 pandemic: 
longitudinal analyses of adults in the UK COVID-19 Mental Health & Wellbeing 
study. The British Journal of Psychiatry, 2020: p. 1-8. 
75. Paulhus, D.L., Socially desirable responding: The evolution of a construct. The role 
of constructs in psychological and educational measurement, 2002. 49459. 
76. Rawlings, G.H., et al., A pilot randomised controlled trial of a home-based writing 
intervention for individuals with seizures. Psychology & health, 2018. 33(9): p. 1151-
1171. 
77. Novakova, B., et al., Coping with stress: A pilot study of a self-help stress 
management intervention for patients with epileptic or psychogenic nonepileptic 









Appendix 2 - A Demonstration of calculations 
 
Example of working out trend, level and stability for participant one on the daily WSAS 
measure within phases 
 Within conditions  
Description Baseline Intervention Phase 
Total number of data points 7 49 
Mean 22.43 15.9 
Median 22 18 
Range 16-27 9-24 
Stability Envelope 22 x 0.25 = 5.5 
Envelope = 22 ± 5.5 
16.5 – 27.5 
 
Percentage of points in stability 
envelope 
100% 65% 
Relative level change 
(median second half – median 
first half) 
+2 deterioration  -9 improvement 
Absolute level change 
(first value – last value) 
-5 improvement -14 improvement 
Mid date first half 2 19.5 
Mid date second half 6 44.5 
Mid rate first half 20 19 
Mid rate second half 22 10 
Stability 71.42% 95.12% 












Stability The data was variable in the baseline phase and stable in the 
intervention phase 
Trend Baseline: accelerating – deteriorating 
Intervention: decelerating - improving 
Absolute level change First value of the intervention – last value of the baseline = +2 
deterioration 
Relative level change Median of first half of the intervention – median of second half of the 
baseline = -3 improvement 
Median level change Median of the intervention phase – median of the baseline phase = -4 
improvement 
Mean level change Mean of the intervention – mean of the baseline = -6.53 improvement 
Percentage of non-
overlapping data 
Lowest value of baseline = 16 
Number of values equal to or below 16 in the intervention phase = 
22/49 
Number of values above 21/number of sessions x 100 = 22/49 x 100 
= 44.9% 
Percentage of overlapping 
data 
Lowest value of baseline = 16 
Number of values equal to or above 16 in the intervention phase = 
27/49 
Number of values on or below 16/number of sessions x 100 = 27/49 x 
100 = 55.1% 
Effect size; percentage 
exceeding the mean 
Median of baseline = 22 
Number of intervention data points below 22 = 42 
Value from earlier step divided by the number of data points in the 
intervention phase; 42/49 = 0.8571 
Multiply value in earlier step by 100; 0.8571 x 100= 85.71% 









Figure showing trend lines applied using the “split middle” method – each phase was divided in half. 
The median of each half was marked on the mid-point of each half and a line connecting these points 
was the trend line. This was moved to a point where there were an equal number of data points above 







Example of RCI and CSC calculations 








RCI calculation  
Standard error of the mean (SEM) 
Formula:  SD x √(1 − 𝑟)   
r = reliability of measure 
12.15 x √0.16 
12.15 x 0.4 
= 4.86 
Standard error of difference (Sdiff) 
Formula:  SEdiff = √2 𝑥 𝑆𝐸𝑀2 
  √2 𝑥 4.862 
 √2 𝑥 23.62 
 √47.24 
 = 6.87 
RCI formula: (post treatment score – pre 
treatment score/Sdiff) 
(24 – 42 / 6.87) 
 = -2.62 
Is the score greater than ±1.96? Yes. Therefore, RCI criteria is met 
CSC calculation  
Formula: (SD functional population x M 
dysfunctional population) + (SD 
dysfunctional population x M functional 
population) / (SD functional 
population + SD dysfunctional population) 
(7.52 x 28.98) + (12.15 x 18.53) / (7.52 + 12.15) 
443.07 / 19.67 
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This is a critical review of the project. Firstly, the key findings of the thesis will be presented. 
Following this, a background section reflects on my reasons for settling on this research 
project. In doing so, it will cover points relevant to the thesis as a whole. Following this, the 
review will proceed through sections focusing on the systematic review portion of the thesis. 
It will then consider the empirical paper before concluding with some potential future 
research and general remarks on the thesis. 
 
2. Key results of the thesis 
The systematic review was focused on the experience of stigma amongst people with a 
diagnosis of functional neurological disorder (FND). A systematic search retrieved 13 papers 
and a meta-ethnography identified four themes: delegitimization; excluded, isolated and 
abandoned – the social cost of stigma; the cost of attempts to manage stigma; and threats to 
identity and the meaning of mental health. The review highlighted the experience of stigma 
for individuals with an FND diagnosis and the effects that stigma has on their daily lives. 
 
The empirical paper investigated the benefits of a mindfulness training app for functional 
seizures (FS). Five participants were recruited with support from a third-sector organisation. 
Results showed some variation, with two participants showing benefits from the intervention 
across measures of quality of life, distress, experiential avoidance and mindfulness in the 
study and a further two who completed the intervention not showing significant benefits on 
the measures used, the fifth participant did not complete the intervention and did not show 
improvements before departing the study. However, all participants who completed the 
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intervention described it in a positive light and also commented on aspects of it that could be 
improved. 
 
3. Why this research? 
I have always been attracted to integrating ideas, to looking at things from different, 
sometimes opposing perspectives and recognising the benefits that each position brings. This 
may have roots in my professional background having come from a Social Science informed 
background to one grounded in Psychology. I also enjoy the idea of being pragmatic and of 
research having some real-world impact. FND brought together a lot of these threads, the 
condition itself being one that connects ideas about the body, the brain and the mind in an 
often complex and overlapping nature. I was excited by the idea of getting involved in 
research in this area.  
 
Again, my choice of method for the empirical paper reflected these threads – integrating both 
quantitative and qualitative methods through a single case experimental design respected both 
schools of thought and allowed for a much richer understanding in an intervention study 
compared with relying solely on psychometric measures. As well as this, focusing on the role 
of stigma in the review crossed a number of fields of interest for me including social and 
psychological factors that impact upon health and wellbeing.  
 
4. An issue relating to both papers 
As I looked into this area, it became clear that language was an important factor to consider. 
This was apparent for a number of reasons including the variety of language used to describe 
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FND conditions and also the history and stigma associated with the terms used to describe 
people experiencing FND [1]. While my initial reaction to this difficulty was to adopt the 
terminology used in some of the most recent, widely cited research – psychogenic non-
epileptic seizures (PNES) [2, 3], it quickly became apparent in my discussions with 
FNDHope (a patient-led FND advocacy group) that this term was considered to be 
stigmatising and that it placed blame upon people experiencing FND for their condition. This 
was largely due to the fact that the term implied pure psychological cause for the condition in 
the “psychogenic” part of the title and also defined the condition by exclusion in the “non-
epileptic” part of the title. In the development of the research project, I became aware that 
people who experience functional seizures often experience stigma [4] and that the name 
used can serve to promote this. As a result, the term functional seizures (FS) utilised by FND 
advocacy groups was adopted for the study. In managing this dilemma, I experienced first-
hand the importance of language and how researchers have the ability to influence the wider 
narrative through the language adopted. I felt that this was a very important lesson learned in 
undertaking this research. 
 
5. Issues relating to the systematic review 
In order to undertake the systematic review a meta-ethnographic [5] approach was adopted. 
This is a well-known approach that has frequently been applied to healthcare topics [6]. It 
was adopted for this review as it has the ability to build a “whole” from the sum of the parts 
of qualitative papers that reported on stigma in FND to a greater or lesser degree. Syntheses 
of qualitative research have been both lauded and critiqued. One frequent critique of this type 
of review is the fact that the process involves the combination of studies that approach 
research from differing traditions with differing underlying philosophical assumptions [7]. 
However, in focusing on qualitative research this review brought together studies from a 
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similar philosophical orientation. A further critique of this method relates to the quality 
appraisal score. Some argue that imposing a quality appraisal score on qualitative research 
involves the imposition of positivist principles upon research that draws from the opposing 
philosophical standpoint [8] with its concerns for the unique experience of the individual at 
its core. However, in undertaking the systematic review it felt important to conduct a quality 
analysis in order to demonstrate a degree of consistency, highlighting the quality of the 
papers that made up the synthesis. In order to manage this dilemma, the ratings were 
displayed for the reader who may decide how they wish to apply them to their understanding 
of the review rather than adopting them to rule studies in or out of the review. Additionally, 
this approach facilitated a check that no theme relied solely on evidence from papers with 
lower ratings. This approach I feel served this purpose and did not fall in to the territory of 
uncritical adoption of such a technique [8]. While other methods may be appropriate, the 
review displays a clear strength in that it clearly outlines the search strategy and method that 
was used in order to arrive at the result. This approach contrasts with less rigorous narrative 
reviews that do not report this information [9]. 
 
As noted above, language and terminology are important issues when considering FND. This 
became apparent when conducting the literature search. To date, there is no consensus on 
terminology for FND or the conditions associated with it. Indeed, this is reflected in the 
evidence base that uses a variety of terms for FND conditions. This presented a challenge 
when undertaking the search. As can be seen in the strategy, this involved including a variety 
of potential search terms for FND, drawing on strategies used in other reviews in order to 
ensure that none were missed. While this led to a time-consuming phase of reviewing papers 
for eligibility for the review, I believe it was necessary in order to ensure the parameters of 




In conducting the review, at times I felt a tension between sociological and psychological 
constructs in developing a response to stigma. For example, when considering the wider 
implications of the review I was drawn to make pragmatic suggestions about what should be 
done to address stigma that clearly causes ongoing difficulty for a lot of people. In the report 
I focused on the societal changes or shifts that are required. However, I did note a draw 
within myself to formulate these difficulties using psychological models. Indeed, 
psychological models exist that would actively support some of the experiences reported by 
participants as a result of the stigma they encountered. For example, at the core of 
compassion focused therapy [10] there is a focus on dealing with shame. While this may be 
useful clinically on an individual basis, it does not address the source of the problem. In 
recognising my position as a researcher on the topic of stigma it felt incredibly important not 
to perpetuate the idea that the problem and solution is located within the individual. Stigma is 
a societal issue and it felt greatly important to use the platform and position that research 
brings in a way that promotes positive social change rather than perpetuating the idea of 
personal responsibility in the face of social difficulty. I felt that this was an important lesson 
in my development as a researcher and the embedding of ethics within my research practice. 
 
6. Issues relating to the empirical paper 
The empirical paper used a single case experimental design (SCED) methodology. A clear 
benefit of using this method was the ability to integrate the qualitative experience of 
participants into the study. The lived experience of participants who take part in research 
investigating treatment methods and techniques tends to be lacking from the majority of 
research into psychological treatments in favour of psychometric measures. Indeed, this has 
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sometimes been considered an antithesis to quantitative evaluation [11]. While measures 
ensure a degree of standardisation, the individuals taking part in these studies are not 
“standardised” in the same way and will often have a diverse range of responses to the 
treatment. In taking this approach the study sought to bridge the gap between idiographic and 
nomothetic approaches to research, recognising the strengths of both quantitative and 
qualitative data, viewing both as complimentary rather than as dyadic, an approach that has 
been argued for elsewhere [12]. As a result, the strengths of this study revolve around the 
ability of the design to identify change on an individual level, this being something that can 
be obscured by larger group designs [13]. 
 
Considering the ethics of the study, safety was a key concern throughout. As can be seen in 
the proposal, a clear risk protocol was in place for the study. Thankfully, this served its 
purpose, and no participants reported any harm in the course of their participation. However, 
inspecting the data from P4, there are days where they experienced a large number of 
seizures. This was quite an alarming finding. However, P4 did not report any increased 
distress during the weekly check-in telephone calls throughout the study. I followed up with 
this participant upon discovering the number of seizures that she was experiencing, and she 
reported that they were not causing significant distress and included a large number of very 
short absence type seizures.  
 
A further ethical issue raised by this study was the use of a payment for participants. This 
initially came about due to concerns in the design stage regarding the amount of time 
required of participants to take part in the study. The ethical debate around payment has been 
raised time and again [14] with the key concerns that this may coerce people in to taking part. 
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However, it has also been acknowledged that failure to provide remuneration for time spent 
on a project may raise ethical concerns [14]. The payment in this case was intended to 
compensate for the time that participants spent completing measures on a regular basis 
throughout the study. In developing the proposals for this, Health Research Authority (HRA) 
guidance was followed [15] to ensure that the payment was not coercive, was available to all 
participants including those who withdrew from the study and did not encourage risk-taking. 
 
Given the timing of the study, the covid-19 pandemic had a significant impact. Firstly, 
recruitment plans were affected. The initial plan for recruitment had been to make links with 
local branches of third sector support groups and visit meetings of support groups in order to 
recruit to the study face-to-face. However, this was not possible due to the outbreak and 
restrictions that existed throughout and indeed beyond the recruitment and data collection 
phases of the study. As a result, the recruitment strategy was changed to recruit online. This 
proved quite difficult as at the time, many organisations who may have been interested in 
promoting the study appeared to have staff on furlough or were not operational in the usual 
manner. While one organisation was incredibly helpful in listing the study, recruitment 
proceeded quite slowly. There were a number of enquiries which did not result in potential 
participants taking up a place in the study. Quite understandably this was a time where the 
population as a whole experienced a degree of shock and change in their lives and taking part 
in a study which demanded a consistent degree of participation may have been more difficult 
than at other times. The aim was originally to have six participants as had been the norm in 
some similar studies [16]. While six participants were recruited, full datasets were only 
available for four as one participant withdrew, and another became ineligible. Indeed, despite 
six participants being frequently used in this type of study, several similar studies have been 
published with 2-4 participants [17-19]. Therefore, owing to the difficulties recruiting at this 
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time, it was decided to proceed with the four full datasets obtained. In doing so, the study met 
the criteria for methodological soundness advocated by the what works clearing house 
(WWC) guidance on SCED design [20] by making “at least three attempts to demonstrate an 
intervention effect at three different points in time or with three different phase repetitions 
[20 p. 15].” 
 
A limitation in relation to recruitment was the possibility of sample bias. As recruitment was 
online, this limited the possibility of taking part to those who have sufficient IT skills and 
engage with the organisation that advertised the study. Additionally, the recruitment approach 
and time involved in the study meant that only those who had a high level of motivation and 
ability would take part. Furthermore, participants self-confirmed their diagnosis to the 
researcher through their application to take part in the study rather than seeking a video 
electroencephalogram confirmed diagnosis which has been advocated by some in FS research 
[3]. These issues could potentially be addressed in future research by recruiting via the NHS. 
 
Adherence was an issue in the study. While recommendations were made to participants 
about the amount of mindfulness practice that they should complete, failure to adhere to the 
guidance was not used to exclude them from the study at any point. There may have been an 
argument to exclude data from P3 for example who showed low adherence completing only 
one session on some weeks. An alternative approach to managing this may have been to omit 
data from participants who did not complete a pre-determined number of sessions. However, 
including these data may actually add some information around what is realistic for 
participants to manage with this intervention. Indeed, the frequency of between-session 
practice in models such as cognitive behavioural therapy (CBT) is variable with research 
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showing that this is not always completed as planned [21] and that higher completion rates 
are associated with greater outcomes in therapy. Indeed, for the participants who benefitted 
most from this intervention, the rate of adherence was high. 
 
If I were to run a similar study in future, I might reconsider the measures used. Firstly, 
considering the measure of seizure frequency (reported daily), despite two participants 
reporting qualitatively that they had experienced a reduction in seizure frequency, this was 
not detected using the visual methods used. This was likely due to a floor effect as some 
participants reported experiencing zero seizures in the baseline phase which meant that any 
improvement beyond that point could not be detected. Additionally, it was not possible to 
apply reliable change and clinically significant change to this measure as statistical data are 
not available for a self-report seizure measure. Indeed, it has been argued elsewhere that 
seizure frequency alone may not be the most useful outcome measure for FS when used in 
isolation [22]. Furthermore, recent reviews have identified that there is an absence of reliable 
outcome measures available specifically for FND conditions [23, 24]. A useful reliable and 
valid measure might integrate aspects of the other measures used here such as the work and 
social adjustment scale [25], taking into account both the frequency and potentially the 
duration of seizures along with the impact that they have on daily life. A further note on the 
measures was raised in the empirical paper in relation to the use of the acceptance and action 
questionnaire (AAQ-II) [26]. This instrument was developed to measure core concepts of 
experiential avoidance and psychological flexibility which are central to the practice of third-
wave cognitive therapies such as acceptance and commitment therapy (ACT) and 
mindfulness. Underlying theories from these models note that practising mindfulness and 
ACT skills results in individuals developing greater freedom in choosing how they wish to 
respond to thoughts and experiences [27] and throughout the development of third-wave 
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therapies, the AAQ-II has been a central measure [28]. However, the measure has faced 
criticism in relation to its discriminant validity [29, 30].  
 
Similarly, the methods of analysis can be critically analysed. It is worth nothing that SCED 
and the established methods of data analysis were developed primarily to establish evidence 
for behavioural interventions. In particular, the methods such as those in the suite proposed 
by Lane and Gast [31] are perhaps more effective at detecting an effect in scenarios where an 
immediate change is hypothesised compared with an intervention-based study such as this 
one which involves participants who learn a skill or make a change over time. There is no 
specific point in time in a mindfulness or psychotherapeutic intervention where it can be said 
that the conditions are completely in place. This contrasts with behavioural interventions such 
as reinforcement schedules which may be implemented and removed instantly. Indeed, 
through analysing data early in the intervention phase, this may in fact weaken the power of 
these methods to detect a change. For example, Lane and Gast’s [31] method seeks to 
confirm an instant effect. Conversely, it would be hypothesised that the impact of 
mindfulness training or psychotherapy would not be evident until after participants have 
completed the course of therapy or the intervention [32]. It may be useful to consider 
adapting the study design and measuring different phases in this case. For example, obtaining 
a baseline measurement, proceeding to deliver the intervention and measuring again once the 
skills have been learned and applied. However, this approach is not evident in the literature. 
 
Alternative visual methods are available such as the Fisher et. al. [33] conservative dual 
criterion (CDC) method which is reported to have increased accuracy and is less likely to 
report a type 1 error. However, the decision was taken to proceed with the Lane and Gast [31] 
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method due to the comprehensive nature of this method incorporating both within and 
between condition analysis, the fact that it is widely used elsewhere (e.g. [16, 34, 35]) and 
finally, as the guidance for the CDC method only provides direction for datasets containing 
up to 23 points which the intervention phase in the present study exceeded. Additionally, the 
CDC method shares the traits described in the previous paragraph.  
 
Turning to the results, this study broadly found two demonstrations of effect on the key 
outcome measures. As noted in the empirical paper, this does not meet the criterion set out in 
the what works clearing house document [20] which specify that for an effect to be shown in 
a SCED, three replications must be displayed. In the analysis of the study I recognised that it 
did not demonstrate an effect in accordance with these standards as there were two out of the 
four participants who completed the intervention that showed some effect. In doing so I 
wished to uphold quality standards. However, it should be recognised that other research has 
been published reporting an effect with fewer than three demonstrations [18]. Indeed, 
guidance on this is a little unclear, despite WWC [20] acknowledging that an effect may be 
detected without three replications, the paper does not describe how this may be achieved and 
notes that its’ authors may decide whether or not a study constitutes evidence without 
defining how they would go about this. I felt that this raised some issues in relation to what 
we can consider evidence, particularly from a small-scale study such as this. As a 
consequence of the WWC guidance it felt that the study was in limbo on some level – that it 
did not show efficacy on one hand according to the guidance. Yet, it could not be said to be 
ineffective given the positive reports and data from two participants. 
 
7. Future Directions 
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This thesis adds to two important areas in relation to FND – the evidence base for treatments 
and the social understanding of the condition. In doing so it opens up a variety of avenues in 
terms of future research.  
 
Firstly, the systematic review identified stigma as an added difficulty that shapes the 
experience of those experiencing FND in a variety of ways. As identified in the review paper, 
further qualitative studies that explicitly focus on this would be beneficial in order to gain a 
deeper understanding of this experience. Grounded theory may be particularly useful to build 
a greater understanding of stigma with the aim of finding reliable methods to tackle the 
problem. 
 
Considering the empirical paper, this adds to the literature building on the importance of third 
wave ideas of psychological flexibility and experiential avoidance in the make-up of 
functional seizures. Future studies may build on this through adding to the literature about 
what type of intervention works for whom. Considering the identification in this study of 
reducing experiential avoidance as a process that resulted in benefits for participants, ideas 
from process-based therapy [36] which changes the focus of intervention from the diagnosis 
to key processes that maintain difficulties, may be useful for FS given the variety of people 
who present with this difficulty. Indeed, using the integrative cognitive model as a guide to 
identify relevant cognitive processes and subsequently developing evidence for interventions 
targeting these may be a suitable approach to managing the problem that heterogeneity 





Overall, on a personal level this project has provided a steep learning curve in a variety of 
ways. It has challenged me to learn new research methods, to learn about a condition in-depth 
and to apply research to very real-world questions in a pragmatic fashion. I feel that in 
undertaking this project I have learned a set of skills that will support me in developing 
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of FS will be recruited to the study. Participants will be required to speak English to a level where 
they are comfortable completing mindfulness teaching through English. Participants will also need to 
have access to a smartphone or tablet in order to access the intervention. The study will aim to 
recruit between three and six participants. The minimum number of participants for this type of 
study to meet the standard set by Horner et al. (2005) is three. However, four is preferable 
(Kratochwill et al., 2010) and similar studies have set a precedence of six (Barrett-Naylor et al., 
2018). Recruitment will continue on a rolling basis until a full dataset from six participants is 
obtained. Alternatively, recruitment will stop in October 2020 if the minimum number of three 
participants has been reached. A dataset will be considered full where participants have completed a 
minimum of 50% of the intervention and corresponding measures along with a change interview and 
follow-up measures. Participants will be recruited through FS support groups. Ciarán will approach 
relevant support organisations such as FNDHope and online support groups including; NEAD UK, 
NEAD caregivers and NEAD Awareness. 
Exclusion criteria for this study will include addiction, psychosis and suicidality. Mindfulness is 
usually a safe activity but may be experienced as distressing by some in these groups (Kostanski & 
Hassed, 2008). People with an active mindfulness practice at present will also be excluded from the 
study, as will those who are currently engaging in psychotherapy. People with a comorbid diagnosis 
of epilepsy will also be excluded from this study. Participants will be screened by telephone or 
internet communication service using the demographics and screening questionnaire. 
As this study involves a lot of time on the part of participants, a payment in the form of a voucher 
will be provided to them at the end of their participation in the study. This is discussed in further 
detail below. 
 
4. How will participants be recruited and from where?  Be as specific as possible.  Ensure that you 
provide the full versions of all recruitment materials you intend to use with this application (eg 
adverts, flyers, posters). 
 
Recruitment 
Ciaran will contact a number of support organisations and groups that have an interest in 
NEAD/PNES Ciarán will make contact with groups supporting those with NEAD including FNDhope, 
FNDAction, NEAD UK, PNES caregivers and PNES awareness. 
• Ciarán will create social media accounts based on the poster (e.g. 




• Ciarán will make contact with each group via their preferred contact method (e.g. phone, e-mail, 
online form, message via social media) to explain the study and gauge their interest in supporting 
recruitment. 
• Ciarán will provide each group with a copy of the poster containing information about the study 
and contact details. 
• Ciarán will request that they share with their members through any available channels including e-
mail, newsletter, social media, at support groups or through pre-existing panels who are interested 
in research. 
• These groups will be contacted one at a time (one per week) in order to manage potential demand 
and to ensure that the researcher has time to respond appropriately to all interested parties. 
• If these groups meet in person, Ciarán will offer to attend a group meeting to describe the study to 
potential participants. 
• Anybody interested in participating in the research can make contact with Ciarán via e-mail. Ciarán 
will provide an information to participants via e-mail and will discuss any further requests for 
information with participants by phone or e-mail if required. 
When a participant makes contact by e-mail or through direct contact via social media, Ciarán will 
then contact the potential participant by e-mail or phone to explain more about the study and to 
answer any questions.  If participants are still interested, they then will be provided with a 
participant information sheet via e-mail. Participants who wish to continue with the study at this 
point will complete the screening questionnaire with Ciarán by telephone. Participants will be 
informed whether or not they meet the study criteria over the telephone. 
Participants who meet the inclusion criteria for the study will be invited to participate. They will be 
sent a link by text or e-mail to the Qualtrics page where they can consent to participate in the study. 
Potential participants who do not meet the criteria for the study will be provided with a list of 
relevant support agencies. Any data gathered from these individuals will be deleted once this has 
been provided to them. 
Participants will be asked whether they would prefer to receive reminders and links to 
questionnaires by text or by e-mail and this preference will be used throughout the study unless a 
participant changes their preference which they can do by informing the researcher during a weekly 
check in call or by e-mail at any point during the study. 
 
5. Briefly describe your data collection and analysis methods, and the rationale for their use.   
 




A small battery of questionnaires will be collected daily for one week before the intervention and 
daily throughout the intervention. These will include a self-report measure of seizure frequency 
(number of seizures experienced in a day) and the 5-item work and social adjustment scale (Mundt, 
Marks, Shear, & Greist, 2002). This measure was chosen for its psychometric properties, ease of 
completion and its ability to capture changes in functioning. 
 
Additional measures used in this study will be collected pre- and post-intervention, weekly 
throughout the intervention and at one-month follow-up. 
 
The 7-item acceptance and action questionnaire version 2 (Bond et al., 2011) will be used to 
measure psychological inflexibility and experiential avoidance. Both have been shown to play a role 
in NEAD (Dimaro et al., 2014) and mindfulness has been shown to act on both processes (Hooper, 
Villatte, Neofotistou, & McHugh, 2010; Moore & Malinowski, 2009). 
 
The 15 item five factor mindfulness questionnaire (Gu et al., 2016) measures different aspects of 
mindfulness and will be used to assess whether participants develop mindfulness traits through 
using the app. 
 
The CORE-10 (10 items) (Barkham et al., 2013) will be used to monitor participants’ levels of distress 
throughout the study. This measure will also collect data on mood. Both may affect the quality of life 
of people with NEAD. 
A brief change interview (Elliott, 2010) administered by phone post-intervention will assess the 
participants’  experiences of the intervention, qualitative benefits from the intervention and any 
difficulties with the intervention. 
 
Demographic and clinical information for each participant will also be recorded: age, gender, 
ethnicity, occupational status, partnership status, time since diagnosis, other health conditions and 
medication. 
All measures will be collected using Qualtrics online tools. Participants will be sent a link by text or e-
mail requesting that they fill in the measures as required. See links below; 
 
Qualtrics information: 
Consent:  https://lancasteruni.eu.qualtrics.com/jfe/form/SV_3KoXv9TOKPC6skZ 
Weekly measures: https://lancasteruni.eu.qualtrics.com/jfe/form/SV_e99C35uuaRdFm05 
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During the baseline phase, participants will complete measures of work and social adjustment 
(WSAS) and seizure frequency on a daily basis for one week. Participants will receive a prompt each 
day with a link to complete this questionnaire. Participants will also receive a prompt to complete 
weekly measures. Following this, Ciarán will check the trend of the participant’s data to ensure that 
its trend is not already towards a reduction in symptoms and increase in functioning. This is an 
essential step in ensuring the internal validity of the study (Morley, 2017). If it is stable, they will 
begin the intervention phase. If this is not stable, the baseline phase will be extended in three-day 
increments until it reaches stability. Participants will complete the baseline phase at different times. 
It is anticipated that this will happen naturally due to the rolling nature of recruitment in this study. 
However, if a number of participants sign up at the same time, their baseline periods will be 
staggered in order to adhere to the design standards for the study. 
 
Intervention 
Participants will begin completing the exercises in the Smiling Mind application. They will complete 
these in the following order; 
 
Week 1: Complete 6 “introduction to mindfulness” guided sessions. 
Week 2: Complete the first set of 7 sessions of the “mindfulness foundations programme” 
Week 3: Complete the second set of 7 sessions of the “mindfulness foundations programme” 
Week 4: Complete the third set of 7 sessions of the “mindfulness foundations programme” 
Week 5: Complete the fourth set of 7 sessions of the “mindfulness foundations programme” 
Week 6: Complete the fifth set of 7 sessions of the “mindfulness foundations programme” 
Week 7: Complete the sixth set of 7 sessions of the “mindfulness foundations programme” 
 
Participants will be asked not to go past the advised schedule for completing the intervention until 
after their participation in the study is complete. They will be advised that if they wish to do any 




Participants will ideally complete one session each day during the intervention phase. In the event 
that a participant does not manage to complete it on one day, they can complete two the next day.  
 
During the intervention phase, participants will complete daily measures throughout. Participants 
will receive a prompt each day with a link to complete this questionnaire. Participants will also 
receive a prompt to complete weekly measures once per week. 
 
Follow up Phase 
Four weeks after they have completed the intervention, the researcher (Ciarán) will contact each 
participant to complete a brief change interview (Elliott, 2010). These interviews will be recorded 
and transcribed. Participants will also be invited to complete one final set of both the daily and 
weekly measures at this time. 
 
Analysis  
Daily measures will be analysed through visual analysis according to guidance from Lane and Gast 
(2014). This analysis involves plotting all data points from the daily measures on to a graph. From 
this an analysis for each participant will be conducted to assess the change between the baseline 
and the intervention phase. Trend, and stability will also be analysed using this method. This will 
answer the research questions: What effects does a mindfulness training app intervention have on 
quality of life of people with NEAD? Does a mindfulness training intervention delivered through an 
app reduce seizure frequency in people with NEAD? 
 
The remaining quantitative data will be analysed using a reliable change index analysis and measures 
showing reliable change will be further examined through clinically significant change statistics 
(Jacobson & Truax, 1991). A cut off for reliable change and clinically significant change will be 
calculated for each measure and each participants data will be examined to see if their scores 
exceed the cut-off. This approach has been shown to be useful in small sample research of this 
nature (de Souza Costa & De Paula, 2015). This analysis will answer the research questions; Does a 
mindfulness training app intervention lead to a reduction in experiential avoidance?  Does a 
mindfulness training app intervention have an effect on levels of distress in people with NEAD? 
 
Change interview responses will be transcribed and summarised in table format. A brief content 
analysis (Smith, 2000) will identify key themes from the interviews. These data will be used to 
support or to challenge the quantitative data collected in the study and will add the subjective 
experience of participants using the intervention answering the final research question; How do 




At the end of their participation in the study, participants will be provided with a voucher for a 
maximum of £41.05. Where a voucher cannot be obtained in a round amount, the total due will be 
rounded to the nearest available sum. See below for further discussion on this proposal. 
 
6. What plan is in place for the storage, back-up, security and documentation of data (electronic, 
digital, paper, etc.)?  Note who will be responsible for deleting the data at the end of the storage 
period.  Please ensure that your plans comply with General Data Protection Regulation (GDPR) and 
the (UK) Data Protection Act 2018.  
 
 
7. Will audio or video recording take place?         no                 audio              video 
a. Please confirm that portable devices (laptop, USB drive etc) will be encrypted where they are used 
for identifiable data.  If it is not possible to encrypt your portable devices, please comment on the 
steps you will take to protect the data.  
The audio recording device will not be encrypted. However, directly after each interview, the audio 
file will be transferred to the secure University server and saved in an encrypted file. 
 
b What arrangements have been made for audio/video data storage? At what point in the research 
will tapes/digital recordings/files be destroyed?   
 
The encrypted data will be stored on the secure University server until the thesis is examined. After 
this point, the files will be deleted by Ciarán. 
 
Please answer the following questions only if you have not completed a Data Management Plan for 
an external funder 
8a. How will you share and preserve the data underpinning your publications for at least 10 years 
e.g. PURE?  
After the study is concluded, the research supervisor Fiona Eccles will manage the data in line with 
University policy for 10 years. Only the quantitative data and interview transcripts will be retained. 
 
8b. Are there any restrictions on sharing your data?  
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This research project will involve a small sample. As a result there is a small risk that participants 
may be identifiable through their responses. As a result data will not be publicly available but any 
requests to share data will be considered on a case by case basis and this will only be granted to 
genuine researchers. 
 
If any participant requests a copy of their data, this will be provided to them by the researcher at the 
end of their participation in the study 
 
9. Consent  
a. Will you take all necessary steps to obtain the voluntary and informed consent of the prospective 
participant(s) or, in the case of individual(s) not capable of giving informed consent, the permission 
of a legally authorised representative in accordance with applicable law?  yes 
 
b. Detail the procedure you will use for obtaining consent?   
A participant information sheet will be provided to all participants outlining the requirements on 
their part for participation in the study. Additionally, the researcher will discuss this in further detail 
with each participant. Participants will be informed of their right to withdraw from the study. 
 
Consent will be recorded via the completion of an online consent form that participants will 
complete through Qualtrics via the following link; 
https://lancasteruni.eu.qualtrics.com/jfe/form/SV_3KoXv9TOKPC6skZ 
 
10. What discomfort (including psychological eg distressing or sensitive topics), inconvenience or 
danger could be caused by participation in the project?  Please indicate plans to address these 
potential risks.  State the timescales within which participants may withdraw from the study, noting 
your reasons. 
 
This intervention is aimed at improving the psychological wellbeing of participants and is not 
anticipated to cause significant distress.  
 
Mindfulness is generally considered a safe activity and this study uses a low-intensity mindfulness 
programme. Some people describe the risks involved in mindfulness as being similar to exercise 
(Baer & Kuyken, 2016). This comparison says that exercise is good for people’s health but can be 
dangerous at times where we over-do it. Similarly, more intense mindfulness training may be more 
risky for people who have not practised it before. The intervention used here is a low-intensity 





Ciarán will have weekly contact with participants which will allow him to check in with participants 
around any adverse reactions that they may have to the intervention. If a participant experiences 
difficulty as a result of the intervention they will be signposted to the relevant support agency and 
the researcher will have a discussion with them about their continued participation in the study. 
 
Participants will also be given advice on the Participant Information Sheet who to contact if they are 
experiencing distress as a result of their participation in the study. 
 
Participants may withdraw from the study at any time. As noted elsewhere, participants who choose 
to withdraw from the study will remain eligible for a voucher in recognition of the time that they 
have spent completing the study. Participants will be able to withdraw their data up to one week 
after it has been submitted. Following this period, participant’s data may be withdrawn if the 
researcher finds that it is possible to do so without compromising the study. 
 
11.  What potential risks may exist for the researcher(s)?  Please indicate plans to address such risks 
(for example, noting the support available to you; counselling considerations arising from the 
sensitive or distressing nature of the research/topic; details of the lone worker plan you will follow, 
and the steps you will take).   
 
It is not anticipated that any lone working will be required over the duration of this study with the 
exception of potentially attending a local support group run by a community organisation. 
 
All contact with participants and organisations will be made through the researcher’s University e-
mail account, a University mobile phone for research purposes or via social media using an account 
created specifically for the study by the researcher linked with his University e-mail address. 
 
12.  Whilst we do not generally expect direct benefits to participants as a result of this research, 
please state here any that result from completion of the study.   
 
It has been well demonstrated that mindfulness can provide a range of health and wellbeing 
benefits. Participants may find that the intervention provides some benefits to their lives such lower 
levels of distress, an increase in day to day awareness, and an increased ability to engage with 
thoughts and feelings. There is a possibility that the intervention could have a positive effect on the 
frequency of participant’s seizures but this is not guaranteed. Indeed, it may have no effect at all. 
We hope that the information gained from this study will help us to understand the nature of these 
seizures and approaches to treating them in the future. 
 
13. Details of any incentives/payments (including out-of-pocket expenses) made to participants:   
 
Due to the burden on the part of participants a reward is required to encourage participation. 
Participants will be required to complete a part of the intervention daily for 8 weeks, complete 
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measures every day for over 8 weeks, have a weekly phone call and a follow up phone call and 
complete weekly measures. It will not be possible to recruit adequately for the study without this 
funding. Precedence has been set in this area by other universities that have experience in 
supporting this type of study e.g. (Barrett-Naylor et al., 2018; Jinks, 2016; Roche, 2016). In providing 
this payment, the study will abide by the protocols outlined in the research ethics guidebook in the 
compensation of participants (Economic & Social Research Council, 2019). 
 
The maximum payment of £41.05 to be provided has been calculated using the current living wage 
as a guide (living wage of £8.21 x a maximum time spent completing measures and interviews of 5 
hours = £41.05). As a result the payment is not considered coercive or as placing undue coercion on 
participants. The provision of this payment also aims to avoid being paternalistic in nature through 
the provision of a choice of retailers from which participants may choose to receive a voucher.  
 
The researcher will provide this voucher to each participant at the conclusion of their involvement in 
the study. In seeking to address this issue, cash would be the preferable option. However, having 
sought advice on this it appears that because of the University’s finance department regulations this 
is not feasible in this study. A voucher will be provided to each participant. Participants may choose 
a voucher from; Amazon, Tesco, ASDA, Sainsburys or Lovetoshop. The voucher will be provided to 
each participant by the researcher at the end of their participation in the study. Participants who 
withdraw from the study will be provided with a voucher reflecting the time that they spent taking 
part in the study. For example, if a participant withdraws after completing 20% of the total study, 
they will be provided with a voucher for 20% of the maximum payment. 
 
 
14. Confidentiality and Anonymity 
a. Will you take the necessary steps to assure the anonymity of subjects, including in subsequent 
publications? yes 
b. Please include details of how the confidentiality and anonymity of participants will be ensured, 
and the limits to confidentiality.  
 
Anonymity of participants will be maintained throughout this study. Participants will be randomly 
allocated a participant identification number. An encrypted file containing participants’ names and 
corresponding ID numbers will be stored in a separate file on the University’s secure server. 
o Once collected, all data will be moved from the Qualtrics platform to the University’s encrypted 
server. 
o Audio recordings will be deleted once the project has been examined. 
o The typed version of the interview will be made anonymous by removing any identifying 
information including participants’ names. Anonymised direct quotations from interviews may be 
used in the reports or publications from the study. As a result confidentiality cannot be guaranteed 
but anonymity will be as far as is possible. 
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o Participants will be informed of the limits of confidentiality through the following caveat: “if what 
is said during our contact makes me think that you, or someone else, is at significant risk of harm, I 
will have to break confidentiality and speak to a member of staff about this and potentially notify 
the relevant authorities if necessary.  If possible, I will tell you if I have to do this.” 
 
15.  If relevant, describe the involvement of your target participant group in the design and conduct 
of your research.  
 
A panel of people with a diagnosis of NEAD was consulted in the design of this research project. In 
doing this they stated that they valued this piece of research in to the area. Furthermore, highlighted 
that the participant materials provide a clear and concise guide to what is required of participants. A 
final point they highlighted related to ensuring that people who do not have any experience of NEAD 
gain some exposure of NEAD and the difficulties associated with it. This final point will be addressed 
through the dissemination of the research findings through publication, conferences, presentations 
at the doctorate in clinical psychology thesis presentation day and at appropriate conferences. 
 
16.  What are the plans for dissemination of findings from the research?  If you are a student, 
include here your thesis.  
 
The findings of this study will be submitted as a thesis for the Doctorate in Clinical Psychology. 
Findings will be presented to staff, students and the Lancaster University Public Involvement 
Network (LUPIN) at a thesis presentation day. It is hoped that findings will be submitted to a relevant 
journal, for example “Seizure.” Findings will be communicated to all groups that have had contact 
with the study through recruitment or promotion of the study and participants who are interested 
will be provided with a copy of the findings. Findings may also be presented at conferences, special 
interest groups and training events.  
 
17. What particular ethical considerations, not previously noted on this application, do you think 
there are in the proposed study?  Are there any matters about which you wish to seek guidance 
from the FHMREC? 
We recognise that in the provision of an intervention, this study may be different in nature to others 
that have been conducted as part of the DClinPsy programme. We would appreciate any feedback 
about this that the panel feel is important. Additionally, we welcome feedback about the proposal to 




SECTION FOUR: signature 
 
Applicant electronic signature:        Date 11/08/20 
Student applicants: please tick to confirm that your supervisor has reviewed your application, and 
that they are happy for the application to proceed to ethical review   





1. Submit your FHMREC application by email to Becky Case 
(fhmresearchsupport@lancaster.ac.uk) as two separate documents: 
i. FHMREC application form. 
Before submitting, ensure all guidance comments are hidden by going into ‘Review’ 
in the menu above then choosing show markup>balloons>show all revisions in line.   
ii. Supporting materials.  
Collate the following materials for your study, if relevant, into a single word 
document: 
a. Your full research proposal (background, literature review, 
methodology/methods, ethical considerations). 
b. Advertising materials (posters, e-mails) 
c. Letters/emails of invitation to participate 
d. Participant information sheets  
e. Consent forms  
f. Questionnaires, surveys, demographic sheets 
g. Interview schedules, interview question guides, focus group scripts 
h. Debriefing sheets, resource lists 
 
Please note that you DO NOT need to submit pre-existing measures or handbooks which 
support your work, but which cannot be amended following ethical review.  These should 
simply be referred to in your application form. 
2. Submission deadlines: 
i. Projects including direct involvement of human subjects [section 3 of the form was 
completed].  The electronic version of your application should be submitted to 
Becky Case by the committee deadline date.  Committee meeting dates and 
application submission dates are listed on the FHMREC website.  Prior to the 
FHMREC meeting you may be contacted by the lead reviewer for further clarification 
of your application. Please ensure you are available to attend the committee 
meeting (either in person or via telephone) on the day that your application is 
considered, if required to do so. 
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ii. The following projects will normally be dealt with via chair’s action, and may be 
submitted at any time. [Section 3 of the form has not been completed, and is not 
required]. Those involving: 
a. existing documents/data only; 
b. the evaluation of an existing project with no direct contact with human 
participants;  
c. service evaluations. 
3. You must submit this application from your Lancaster University email address, and copy 































Applicant: Ciarán Foley  
Supervisor: Fiona Eccles 
Department: DHR 
FHMREC Reference: FHMREC19142 (amendment to FHMREC19037) 
 
18 August 2020 
 
Re: FHMREC19142 (amendment to FHMREC19037) 
A case series investigating the benefits of a mindfulness training smartphone 





Thank you for submitting your research ethics amendment application for the above project 
for review by the Faculty of Health and Medicine Research Ethics Committee (FHMREC). The 
application was recommended for approval by FHMREC, and on behalf of the Chair of the 
Committee, I can confirm that approval has been granted for the amendment to this research 
project.  
 
As principal investigator your responsibilities include: 
- ensuring that (where applicable) all the necessary legal and regulatory requirements 
in order to conduct the research are met, and the necessary licenses and approvals 
have been obtained; 
- reporting any ethics-related issues that occur during the course of the research or 
arising from the research to the Research Ethics Officer at the email address below 
(e.g. unforeseen ethical issues, complaints about the conduct of the research, adverse 
reactions such as extreme distress); 
- submitting details of proposed substantive amendments to the protocol to the 
Research Ethics Officer for approval. 
 









Dr. Elisabeth Suri-Payer,  
Interim Research Ethics Officer, Secretary to FHMREC. 
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Appendix B – Participant information sheet 
 
Participant Information Sheet 
 
A case series investigating the benefits of a mindfulness training smartphone application 
for non-epileptic attack disorder (NEAD). 
 
For further information about how Lancaster University processes personal data for 
research purposes and your data rights please visit our webpage: 
www.lancaster.ac.uk/research/data-protection 
 
My name is Ciarán Foley and I am conducting this research as a trainee clinical psychologist 
as part of the Doctorate in Clinical Psychology at Lancaster University, United Kingdom. 
 
What is the study about? 
The purpose of this study is to investigate whether a smartphone-based mindfulness training 
app provides any benefits for people with experience of non-epileptic attack disorder (NEAD). 
 
Why have I been approached? 
You have been approached because you are part of a group providing support to people 
experiencing NEAD/PNES. The study requires information from people who have a diagnosis 
of NEAD or PNES who are interested in taking part in research on a mindfulness app. 
 
Do I have to take part? 
No.  It’s completely up to you to decide whether or not you take part.  
 
What will I be asked to do if I take part? 
If you decide you would like to take part, your main involvement will be to complete a 
mindfulness training programme over an 8-week period and submit responses to 
questionnaires on a daily and weekly basis for a week before the intervention, during the 
intervention itself and 4 weeks after you have finished. The mindfulness app is called “Smiling 
Mind” and is widely available online and through the Apple “app store” and the Google “play 
store.” The app provides a range of mindfulness training programmes and this study will focus 
on two of these. If you might want to take part, please do not engage with this app before 
the study begins as doing so could interfere with the results. 
 
The study will involve completing exercises from the app each week. You will also have weekly 
phone contact with the researcher where you can discuss your experience and any issues that 
may arise from your engagement with the intervention. As part of the study, you will be asked 
to complete 2 brief questionnaires every day and also up to 3 questionnaires once each week. 
All questionnaires will be submitted online and can be completed using a smartphone, tablet 
or a computer. Daily questionnaires can be completed in approximately 1 minute and weekly 




Before you start the study, you will be asked to complete a screening interview by telephone. 
If you do not meet the screening criteria, then you will not be able to take part in the study 
and any information gathered about you will be deleted. If you do meet our eligibility criteria 
you will be invited to complete some more brief questionnaires. After 1 week of completing 
the daily and weekly measures, you will receive directions to begin using the app. From this 
point on you will continue to complete the daily and weekly measures and receive telephone 
support each week from the researcher.  
 
Your active participation in the study is estimated to take 10 weeks and you will be contacted 
4 weeks after this time to complete a follow up questionnaire online and a brief interview 
over the phone. The measures used in this study can be completed in a couple of minutes 
(less than 2 minutes for the daily questionnaire and 10 minutes for the weekly 
questionnaires). The time required to complete the mindfulness training will vary. The app 
provides a 6-session introduction to mindfulness lasting 15 minutes in total and a 42-session 
foundation course with exercises ranging from 1-40 minutes with an average duration of 9 
minutes. We anticipate that completing the mindfulness training and completing the 
questionnaire will take an average of ten minutes each day. 
Below is a flowchart outlining the main phases of the study; 
 
 
The main procedure for taking part in the study is as follows in some more detail; 
 
Contact the researcher by e-mail to express your interest in taking part in the study 







































The researcher will provide you with a copy of this info sheet via e-mail 
 
The researcher will be available by telephone or e-mail to discuss the study in more detail 
 
If you wish to take part, you will be invited to complete a brief telephone interview with 
the researcher to see if you meet the screening requirements and to gain some 
background information about you. 
 
If you meet the criteria for the study and wish to take part, you will directed to a website 
where you can consent to participate in the study. 
 
You will be sent a link to complete a weekly questionnaire online. You will be sent a link 
to complete this each week during your participation in the study. 
 
For the next week you will be sent daily questionnaires to complete each day. You will 
receive your preference of an e-mail or a text message reminder to complete these along 
with a link to the website where they can be completed. 
 
After one week, you will begin the mindfulness intervention. The researcher will direct 
you to complete a set number of exercises from the app each week. The researcher will 
contact you once per week to check in around your experience of the intervention. 
 
This will be repeated for the next 7 weeks meaning that you will have completed 8 weeks 





4 weeks after finishing the intervention you will be asked to complete the questionnaires 
once more and you will be invited to take part in a telephone interview with the 
researcher to discuss your experience of taking part in the study. 
Expenses and payments 
In recognition of the time commitment for participation in the study, you will be provided 
with a voucher worth a total of £40.75 for a retailer of your choice from a selection from 
Amazon, Tesco, ASDA, Sainsburys or Lovetoshop.  
 
If you wish to withdraw from the study, you will still be entitled to a voucher. This will be 
calculated pro-rata for the time you have spent completing the study. For example a person 
who withdraws after completing half of the things required by the study will receive half of 
the total payment. 
 
You should note that acceptance of this voucher may bring liability for tax or could count as 
income towards your means assessment for benefits. We strongly recommend that you check 
this before accepting the payment by contacting HM Revenue & Customs on 0300 200 3300 
and/or your local job centre plus on 0800 169 0310 to discuss this before accepting the 
voucher. Additionally, you have the right to decline this voucher if you so wish and still 
participate in the study. 
 
What will happen if I wish to withdraw from the study? 
 
You have the right to withdraw from the study at any time after beginning to take part. If you 
do choose to withdraw from the study, the information already collected from you may not 
be erased and may be used in the analysis of the project. 
 
Will my data be identifiable? 
The information you provide is anonymous. The data collected for this study will be stored 
securely and only the researchers conducting this study will have access to this data: 
o Audio recordings from the follow up interview will be deleted once the project has 
been examined. 
o The files on the computer will be encrypted (that is no-one other than the researcher 
will be able to access them) and the computer itself password protected. These will 
be deleted 10 years after the project has been examined.  
o The typed version of your interview will be made anonymous by removing any 
identifying information including your name. Anonymised direct quotations from your 
interview may be used in the reports or publications from the study, so your name will 
not be attached to them. 
o All your personal data will be confidential and will be kept separately from your 
interview and survey responses. 
There are some limits to confidentiality: if what is said during our contact makes me think 
that you, or someone else, is at significant risk of harm, I will have to break confidentiality and 
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speak to a member of staff about this and potentially notify the relevant authorities if 
necessary.  If possible, I will tell you if I have to do this. 
 
What will happen to the results? 
The results will be summarised and reported in a thesis and may be submitted for publication 
in an academic or professional journal or presented at conferences. I will also give you a copy 
of the results if you would like to see them. 
 
Are there any risks? 
There are minimal risks anticipated with participating in this study. Participation in this study 
does require that you give up some of your time. It is important that during the study you 
maintain a healthy life balance making time for the things that are important in your life. It is 
important to note that in rare cases people may find the mindfulness exercises difficult. If this 
comes up, the researcher will discuss possible support options for you and will have a 
discussion with you about your participation in the study going forward. 
 
The study is an experimental study, and it is hoped that it will bring some positive changes for 
you. However, this is not guaranteed. Therefore, it is important for you to note that there 
may be no positive changes in the frequency of your seizures as a result of your participation. 
 
Are there any benefits to taking part? 
You may find that the intervention provides some benefits to your life such as your level of 
distress, your awareness and your ability to engage with thoughts and feelings. There is a 
possibility that the intervention could have a positive effect on the frequency of your seizures 
but this is not guaranteed. Indeed, it may have no effect at all. We hope that the information 
gained from this study will help us to understand the nature of these seizures and approaches 
to treating them in the future. 
 
Who has reviewed the project? 
This study has been reviewed and approved by the Faculty of Health and Medicine Research 
Ethics Committee at Lancaster University. 
 
Where can I obtain further information about the study if I need it? 




Trainee Clinical Psychologist, Doctorate in Clinical Psychology, Faculty of Health and Medicine, 
Lancaster University, Lancaster , LA1 4YT 
email: c.foley@lancaster.ac.uk 
Tel: 0750 840 6248 
 
Research Supervisor 
Dr Fiona Eccles 
Research Tutor, Doctorate in Clinical Psychology, Faculty of Health and Medicine, Lancaster 
University, Lancaster , LA1 4YT  





Dr Antonia Kirkby 
Consultant Clinical Neuropsychologist, Neuropsychology Lead for Non-Epileptic Attack 
Disorder Service, Salford Royal Hospital, Salford, M6 8HD 
Tel: +44 (0)161 206 4694, email: Antonia.kirkby@srft.nhs.uk 
 
Complaints  
If you wish to make a complaint or raise concerns about any aspect of this study and do not 
want to speak to the researcher, you can contact:  
 
Ian Smith Tel: (01524) 592282 
Research Director, Doctorate in Clinical Psychology; Email: i.smith@lancaster.ac.uk  
Faculty of Health and Medicine 




If you wish to speak to someone outside of the Clinical Psychology Doctorate Programme, you 
may also contact:  
 
Professor Roger Pickup Tel: +44 (0)1524 593746  
Associate Dean for Research Email: r.pickup@lancaster.ac.uk  
Faculty of Health and Medicine  
(Division of Biomedical and Life Sciences)  





















Appendix C – Recruitment Poster 




I am a trainee Clinical Psychologist currently enrolled on the Doctorate in Clinical Psychology in 
Lancaster University. I am seeking participants with experience of functional seizures also known as 
psychogenic non-epileptic seizures (PNES) or non-epileptic attack disorder (NEAD) who are interested 
in practising mindfulness using a smartphone app. My study is investigating whether this form of 
mindfulness training can provide any benefits for functional seizures. 
If you decide to participate, you will be invited to complete a mindfulness training programme using 
a smartphone app over an 8-week period. You will be asked to complete a series of questionnaires for 
the duration of the study along with an interview over the phone 4 weeks after you’ve finished. 
The study takes part over a long period of time and in recognition of the time spent participating, we 
can offer participants a voucher for £41.05 in recognition of the time spent contributing to the 
research. Participants who meet the criteria for the study and are interested in taking part will be 
selected to do so on a first come first served basis. 
To be eligible for the study, potential participants should be: 
 
• Over 18 years old. 
• Fluent in English. 
• Have access to a smartphone or tablet. 
• Diagnosed with FS/NEAD/PNES 
If you would like more information please contact:  
• Not currently diagnosed with epilepsy. 
• Not currently experiencing difficulty with 
addiction. 
• Not already practicing mindfulness daily 
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Ciarán Foley by e-mail at c.foley@lancaster.ac.uk  




























Appendix D – Demographics and screening questionnaire 
Demographics and screening questionnaire; 
 
Name: 





What stage of education did you reach?  
Relationship status: 
How long have you been experiencing symptoms of NEAD? 
When were you diagnosed with NEAD? 
What treatments have you had for NEAD to date? 
Are you experiencing any other health difficulties? 
Have you received any other mental health diagnosis? 
Are you taking any medications at present? 
Do you currently experience epilepsy? 
Have you been diagnosed with epilepsy in the past? 
Are you currently engaged in any form of psychotherapy? 
Have you had any psychological treatment or psychotherapy in the past? 
Do you practice mindfulness regularly? 
Do you have access to a smartphone or laptop? 
Are you confident in your ability to use a smartphone app and to complete online questionnaires 
with support? 
Have you experienced any episodes of psychosis recently? 
Have you recently experienced a dependence on any substance? 
Have you had any thoughts recently about ending your life? 
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Appendix F – Resources for Participants 
Resource List  
 
Resources in the event of distress 
Should you feel distressed either as a result of taking part, or in the future, the following 
resources may be of assistance; 
 
If you need immediate help: 
In an emergency: 
 Call 999 
 Go to your local A&E department 
 
If you're in crisis and need to speak to someone: 
 Call NHS 111 (for when you need help but are not in immediate danger) 
 Contact your GP and ask for an emergency appointment 
 Contact the Samaritans (details below) 
 Use the 'Shout' crisis text line - text SHOUT to 85258 
  
Samaritans 
Available 24 hours a day to provide confidential emotional support for people who are 
experiencing feelings of distress, despair or suicidal thoughts. 
 www.samaritans.org 
 116 123 (free to call from within the UK and Ireland), 24 hours a day 
 Email: jo@samaritans.org 
  
 
NEAD support groups; 
 
FND Dimensions 





Provide advice and information and lobby on behalf of people with NEAD. 
www.fndhope.org 
FNDAction 
Provide advice and information and lobby on behalf of people with NEAD. 
www.nonepilepticattackdisorder.org.uk 
 





Mind offers advice, support and information to people experiencing a mental health difficulty 
and their family and friends. Mind also has a network of local associations in England and 
Wales to which people can turn for help and assistance. 
Lines are open Monday to Friday 9am to 6pm (except bank holidays).  
 www.mind.org.uk 
 InfoLine: 0300 123 3393 to call, or text 86463  
 Email info@mind.org.uk 
  
Campaign Against Living Miserably (CALM) 
A helpline for men in the UK who are down or have hit a wall for any reason, who need to talk 
or find information and support. 
 www.thecalmzone.net 
 Helpline for men: 0800 58 58 58 
 Webchat: www.thecalmzone.net/help/webchat/ 
5pm to midnight, every day of the year 
  
Sane 
SANE services provide practical help, emotional support and specialist information to 
individuals affected by mental health problems, their family, friends and carers. 
 Support Forum: www.sane.org.uk 
 Saneline: 0300 304 7000 (local rate on BT landlines) Open 4:30-10:30pm every day 
  
NHS mental health services 
Find information, advice and local services on the NHS website. You can also get advice from 















Appendix G – Links to further information 
Links to consent and questionnaires on Qualtrics 
Consent:  https://lancasteruni.eu.qualtrics.com/jfe/form/SV_3KoXv9TOKPC6skZ 
Weekly measures: https://lancasteruni.eu.qualtrics.com/jfe/form/SV_e99C35uuaRdFm05 
Daily measures:  https://lancasteruni.eu.qualtrics.com/jfe/form/SV_25WPKn7Vr7tTe4J 
Link to information about the mindfulness training programme 
www.smilingmind.com 
https://apps.apple.com/gb/app/smiling-mind/id560442518 
https://play.google.com/store/apps/details?id=com.smilingmind.app&hl=en_GB 
 
